Publications in Journals, Dietmar Fuchs

 Division of Biological Chemistry, Biocentre, Innsbruck Medical University  

 

 

Cognitive deterioration in Alzheimer’s disease is accompanied by increase of plasma neopterin. Blasko I, Knaus G, Weiss E, Kemmler G, Winkler C, Falkensammer G, Griesmacher A, Wurzner R, Marksteiner J, Fuchs D. J.Psychiatr.Res. (2006), in press.

 

Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients. Brandacher G, Winkler C, Aigner F, Schwelberger H, Schroecksnadel K, Margreiter R, Fuchs D, Weiss HG. Obes.Surg. (2006) 16: 541-548.

 

Importance of the N-distal AP-2 binding element in Nef for simian immunodeficiency virus replication and pathogenicity in rhesus macaques. Brenner M, Munch J, Schindler M, Wildum S, Stolte N, Stahl-Hennig C, Fuchs D, Matz-Rensing K, Franz M, Heeney J, Ten Haaft P, Swigut T, Hrecka K, Skowronski J, Kirchhoff F. J.Virol. (2006) 80: 4469-4481.

 

Detection of serum neopterin for early assessment of dengue virus infection. Chan CP, Choi JW, Cao KY, Wang M, Gao Y, Zhou DH, Di B, Xu HF, Leung MF, Bergmann A, Lehmann M, Nie YM, Cautherley GW, Fuchs D, Renneberg R, Zheng BJ. J.Infect. (2006), in press.

 

Possible placental exchange of neopterin as indicated by significant correlations in matched maternal neonatal blood samples at delivery. Hammerer-Lercher A, Puschendorf B, Fuchs D, Mair J, Tews G, Shebl O, Sommer R. Clin.Chim.Acta (2006) 365: 350-351.

 

Association between neopterin in cord blood, urinary neopterin in early childhood and the development of atopic dermatitis, asthma and hay fever. Horak E, Murr C, Streif W, Schroecksnadel K, Schennach H, Fuchs D. Pediatr.Allergy Immunol. (2006) 17: 11-16.

 

Monitoring tryptophan metabolism in chronic immune activation. Schrocksnadel K, Wirleitner B, Winkler C, Fuchs D. Clin.Chim.Acta (2006) 364: 82-90.

 

Method for urinary neopterin measurements by HPLC . Schroecksnadel K, Winkler C, Fuchs D. J.Biochem.Biophys.Methods (2006) 66: 99-100.

 

Relationship between homocysteine and neopterin concentrations in patients with gynecological cancer. Schroecksnadel K, Frick B, Winkler C, Fuith LC, Fuchs D. Cancer Lett (2006) 240: 198-202.

 

Tryptophan degradation increases with stage in patients with rheumatoid arthritis. Schroecksnadel K, Winkler C, Duftner C, Wirleitner B, Schirmer M, Fuchs D. Clin.Rheumatol. (2006) 25: 334-337.

 

Immune activation in autism. Sperner-Unterweger B, Winkler C, Fuchs D. Pediatr.Neurol. (2006) 34: 333.

 

[Anti-inflammatory potential of Padma 28–review of experimental data on the antiatherogenic activity and discussion of the multi-component principle].

Ueberall F, Fuchs D, Vennos C. Forsch.Komplementarmed. (2006) 13 Suppl 1: 7-12.

 

Human granulocytic anaplasmosis in Austria: epidemiological, clinical, and laboratory findings in five consecutive patients from Tyrol, Austria. Walder G, Fuchs D, Sarcletti M, Berek K, Falkensammer B, Huber K, Petrovec M, Dierich MP, Wurzner R. Int.J.Med.Microbiol. (2006) 296 Suppl 40: 297-301.

 

Beer down-regulates activated peripheral blood mononuclear cells in vitro. Winkler C, Wirleitner B, Schroecksnadel K, Schennach H, Fuchs D. Int.Immunopharmacol. (2006) 6: 390-395.

 

In vitro testing for antiinflammatory properties of compounds. Winkler C, Ueberall F, Fuchs D. Clin.Chem (2006) 52: 1201-1202.

 

Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study. Yilmaz A, Fuchs D, Hagberg L, Nillroth U, Stahle L, Svensson JO, Gisslen M. BMC.Infect.Dis. (2006) 6: 63.

 

Atorvastatin suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells. Schroecksnadel K, Frick B, Winkler C, Wirleitner B, Weiss G, Fuchs D. Clin.Chem Lab Med. (2005) 43: 1373-1376.

 

Temporarily controlled HIV-1 replication after intravenous immunoglobulin treatment of Guillain-Barre syndrome. Gisslen M, Fredman P, Fuchs D, Lekman A, Rosengren L. Scand.J.Infect.Dis. (2005) 37: 877-881.

 

Relationship between homocysteine and neopterin concentrations in patients with gynecological cancer. Schroecksnadel K, Frick B, Winkler C, Fuith LC, Fuchs D. Cancer Lett (2005), in press

 

Tryptophan degradation increases with stage in patients with rheumatoid arthritis. Schroecksnadel K, Winkler C, Duftner C, Wirleitner B, Schirmer M, Fuchs D. Clin.Rheumatol. (2005) 1-4.

 

Anti-inflammatory compound resveratrol suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells in vitro . Schroecksnadel K, Winkler C, Wirleitner B, Schennach H, Weiss G, Fuchs D. Clin.Chem Lab Med. (2005) 43: 1084-1088.

 

Possible placental exchange of neopterin as indicated by significant correlations in matched maternal neonatal blood samples at delivery . Hammerer-Lercher A, Puschendorf B, Fuchs D, Mair J, Tews G, Shebl O, Sommer R. Clin.Chim.Acta (2006) 365: 350-351.

 

Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro. Wirleitner B, Schroecksnadel K, Winkler C, Schennach H, Fuchs D. Immunol.Lett (2005) 100: 159-163.

 

Monitoring tryptophan metabolism in chronic immune activation. Schrocksnadel K, Wirleitner B, Winkler C, Fuchs D. Clin.Chim.Acta (2006) 364: 82-90.

 

Apoptosis induced by the Tibetan herbal remedy PADMA 28 in the T cell-derived lymphocytic leukaemia cell line CEM-C7H2. Jenny M, Schwaiger W, Bernhard D, Wrulich OA, Cosaceanu D, Fuchs D, Ueberall F. J.Carcinog. (2005) 4: 15.

 

Homocysteine and serum markers of immune activation in primary dystonia. Muller UJ, Frick B, Winkler C, Fuchs D, Wenning GK, Poewe W, Mueller J. Mov Disord. (2005) 20: 1663-1667.

 

Aspirin downregulates homocysteine formation in stimulated human peripheral blood mononuclear cells. Schroecksnadel K, Frick B, Winkler C, Wirleitner B, Schennach H, Fuchs D. Scand.J.Immunol. (2005) 62: 155-160.

 

Neopterin concentrations in blood donors differ between AB0 blood group phenotypes. Murr C, Schroecksnadel K, Schonitzer D, Fuchs D, Schennach H. Clin.Biochem. (2005) 38: 916-919.

 

Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues. Kohl C, Walch T, Huber R, Kemmler G, Neurauter G, Fuchs D, Solder E, Schrocksnadel H, Sperner-Unterweger B. J.Affect.Disord. (2005) 86: 135-142.

 

Serum neopterin for early assessment of severity of severe acute respiratory syndrome. Zheng B, Cao KY, Chan CP, Choi JW, Leung W, Leung M, Duan ZH, Gao Y, Wang M, Di B, Hollidt JM, Bergmann A, Lehmann M, Renneberg I, Tam JS, Chan PK, Cautherley GW, Fuchs D, Renneberg R. Clin.Immunol. (2005) 116: 18-26.

 

Tryptophan degradation in patients with gynecological cancer correlates with immune activation. Schroecksnadel K, Winkler C, Fuith LC, Fuchs D. Cancer Lett (2005) 223: 323-329.

 

Mechanism of neopterin-induced myocardial dysfunction in the isolated perfused rat heart. Balogh A, Mittermayr M, Schlager A, Balogh D, Schobersberger W, Fuchs D, Margreiter J. Biochim.Biophys.Acta (2005) 1724: 17-22.

 

Letter regarding article by Vita et al, „serum myeloperoxidase levels independently predict endothelial dysfunction in humans“. Walter R, Schroecksnadel K, Fuchs D. Circulation (2005) 111: e167-e168.

 

Antioxidants may increase the probability of developing allergic diseases and asthma. Murr C, Schroecksnadel K, Winkler C, Ledochowski M, Fuchs D. Med.Hypotheses (2005) 64: 973-977.

 

Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro. Schroecksnadel K, Winkler C, Wirleitner B, Schennach H, Fuchs D. Clin.Exp.Immunol. (2005) 140: 41-45.

 

Enhanced enzymatic degradation of tryptophan by indoleamine 2,3-dioxygenase contributes to the tryptophan-deficient state seen after major trauma. Pellegrin K, Neurauter G, Wirleitner B, Fleming AW, Peterson VM, Fuchs D. Shock (2005) 23: 209-215.

 

Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Godoy-Tundidor S, Cavarretta IT, Fuchs D, Fiechtl M, Steiner H, Friedbichler K, Bartsch G, Hobisch A, Culig Z. Prostate (2005) 64: 209-216.

 

Telomere length abnormalities and human cancer. Schroecksnadel K, Ueberall F, Fuchs D. Clin.Cancer Res. (2005) 11: 860.

 

Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation. Hainz U, Obexer P, Winkler C, Sedlmayr P, Takikawa O, Greinix H, Lawitschka A, Potschger U, Fuchs D, Ladisch S, Heitger A. Blood (2005) 105: 4127-4134.

 

Neopterin in HIV-1 infection. Wirleitner B, Schroecksnadel K, Winkler C, Fuchs D. Mol.Immunol. (2005) 42: 183-194.

 

Plasma homocysteine and immune activation in patients with malignant melanoma undergoing treatment with IFN-alpha. Frick B, Capuron L, Schrocksnadel K, Musselman DL, Lawson DH, Nemeroff CB, Miller AH, Fuchs D. J.Interferon Cytokine Res. (2004) 24: 311-317.

 

[Soluble interleukin-2 and tumor necrosis factor receptor in liver cirrhosis. Relationship with clinical severity and prognosis]. Garcia RP, Canora LJ, Diez RA, Fuchs D, Wachter H. Med.Clin.(Barc.) (2004) 122: 441-443.

 

DHEA treatment of Alzheimer’s disease: A randomized, double-blind, placebo-controlled trial. Leblhuber F, Haller H, Steiner K, Fuchs D. Neurology (2004) 62: 1030.

 

PADMA 28 modulates interferon-gamma-induced tryptophan degradation and neopterin production in human PBMC in vitro. Neurauter G, Wirleitner B, Schroecksnadel K, Schennach H, Ueberall F, Fuchs D. Int.Immunopharmacol. (2004) 4: 833-839.

 

Influence of neopterin on generation of reactive species by myeloperoxidase in human neutrophils. Razumovitch JA, Fuchs D, Semenkova GN, Cherenkevich SN. Biochim.Biophys.Acta (2004) 1672: 46-50.

 

Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status. Schroecksnadel K, Leblhuber F, Fuchs D. Neurology (2004) 62: 676-677.

 

Moderate hyperhomocysteinemia and immune activation. Schroecksnadel K, Frick B, Wirleitner B, Winkler C, Schennach H, Fuchs D. Curr.Pharm.Biotechnol. (2004) 5: 107-118.

 

Homocysteine is an independent risk factor for myocardial infarction, in particular fatal myocardial infarction in middle-aged women. Schroecksnadel K, Frick B, Fuchs D. Circulation (2004) 110: e37-e38.

 

Possible role of cytokine-induced tryptophan degradation in anaemia of inflammation. Weiss G, Schroecksnadel K, Mattle V, Winkler C, Konwalinka G, Fuchs D. Eur.J.Haematol. (2004) 72: 130-134.

 

Alveolar granulocyte colony-stimulating factor and alpha-chemokines in relation to serum levels, pulmonary neutrophilia, and severity of lung injury in ARDS. Wiedermann FJ, Mayr AJ, Kaneider NC, Fuchs D, Mutz NJ, Schobersberger W. Chest (2004) 125: 212-219.

 

In vitro effects of two extracts and two pure alkaloid preparations of Uncaria tomentosa on peripheral blood mononuclear cells. Winkler C, Wirleitner B, Schroecksnadel K, Schennach H, Mur E, Fuchs D. Planta Med. (2004) 70: 205-210.

 

Statins to reduce risk of depression. Wirleitner B, Sperner-Unterweger B, Fuchs D. J.Am.Coll.Cardiol. (2004) 43: 1132-1133.

 

Down-regulatory effect of N-chlorotaurine on tryptophan degradation and neopterin production in human PBMC. Wirleitner B, Neurauter G, Nagl M, Fuchs D. Immunol.Lett. (2004) 93: 143-149.

 

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, Miller AH. Biol.Psychiatry (2003) 54: 906-914.

 

Rapid measurement of total plasma homocysteine by HPLC. Frick B, Schrocksnadel K, Neurauter G, Wirleitner B, Artner-Dworzak E, Fuchs D. Clin.Chim.Acta (2003) 331: 19-23.

 

Increase in vitamin B-12 during highly active antiretroviral therapy. Fuchs D, Schroecksnadel K, Zangerle R. Am.J.Clin.Nutr. (2003) 78: 1046-1047.

 

Potential role of immune system activation-associated production of neopterin derivatives in humans. Hoffmann G, Wirleitner B, Fuchs D. Inflamm.Res. (2003) 52: 313-321.

 

Tryptophan and quality of life in colorectal cancer. Huang A, Fuchs D, Widner B, Glover C, Henderson DC, Allen-Mersh TG. Adv.Exp.Med.Biol. (2003) 527: 353-358.

 

Kynurenine and neopterin in the aqueous humor of the anterior chamber of the eye and in serum of cataract patients. Laganovska G, Martinsons A, Pitrans B, Widner B, Fuchs D. Adv.Exp.Med.Biol. (2003) 527: 367-374.

 

Interaction of sertraline with Candida species selectively attenuates fungal virulence in vitro. Lass-Florl C, Ledochowski M, Fuchs D, Speth C, Kacani L, Dierich MP, Fuchs A, Wurzner R. FEMS Immunol.Med.Microbiol. (2003) 35: 11-15.

 

Antifungal properties of 5-hydroxytryptamine (serotonin) against Candida species in vitro. Lass-Florl C, Fuchs D, Ledochowski M, Speth C, Dierich MP, Wurzner R. J.Med.Microbiol. (2003) 52: 169-171.

 

Oxidative damage and cytogenic analysis in leukocytes of Parkinson’s disease patients. Leblhuber F, Neurauter G, Fuchs D. Neurology (2003) 60: 729.

 

Association between increased serum cholesterol and signs of depressive mood. Ledochowski M, Murr C, Sperner-Unterweger B, Neurauter G, Fuchs D. Clin.Chem.Lab Med. (2003) 41: 821-824.

 

Altitude sickness: hyperventilatory capacity may predict altitude sickness. Ledochowski M, Fuchs D. BMJ (2003) 327: 106.

 

Re: Personality and the risk of cancer. Murr C, Fuchs D. J.Natl.Cancer Inst. (2003) 95: 1638.

 

Association of increased neopterin production with decreased humoral immunity in the elderly. Murr C, Hainz U, Asch E, Berger P, Jenewein B, Saurwein-Teissl M, Grubeck-Loebenstein B, Fuchs D. Exp.Gerontol. (2003) 38: 583-587.

 

Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Neurauter G, Zangerle R, Widner B, Quirchmair G, Sarcletti M, Fuchs D. Adv.Exp.Med.Biol. (2003) 527: 317-323.

 

Death from pneumonia in patients with progressive dementia. Neurauter G, Fuchs D, Wirleitner B. J.Am.Geriatr.Soc. (2003) 51: 721.

 

Atorvastatin suppresses interferon-gamma -induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines. Neurauter G, Wirleitner B, Laich A, Schennach H, Weiss G, Fuchs D. Clin.Exp.Immunol. (2003) 131: 264-267.

 

The clinical value of the procalcitonin in prediction of severity and outcome in acute pancreatitis. Pindak D, Parrak V, Pechan J, Vavrecka A, Kuzela L, Fuchs D, Irsakova J. Hepatogastroenterology (2003) 50 Suppl 2: ccviii-ccix.

 

Influence of neopterin on the generation of reactive oxygen species in human neutrophils. Razumovitch JA, Semenkova GN, Fuchs D, Cherenkevich SN. FEBS Lett. (2003) 549: 83-86.

 

Prognostic value of tryptophan load test followed by serum kynurenine determination. It’s comparison with pyridoxal-5-phosphate, kynurenine, homocysteine and neopterin amounts. Rudzite V, Fuchs D, Kalnins U, Jurika E, Silava A, Erglis A, Trusinskis K, Jegere S. Adv.Exp.Med.Biol. (2003) 527: 307-315.

 

Increase of haemoglobin levels by anti-retroviral therapy is associated with a decrease in immune activation. Sarcletti M, Quirchmair G, Weiss G, Fuchs D, Zangerle R. Eur.J.Haematol. (2003) 70: 17-25.

 

Longitudinal study of tryptophan degradation during and after pregnancy. Schrocksnadel K, Widner B, Bergant A, Neurauter G, Schennach H, Schrocksnadel H, Fuchs D. Life Sci. (2003) 72: 785-793.

 

Tryptophan degradation during and after gestation. Schrocksnadel K, Widner B, Bergant A, Neurauter G, Schrocksnadel H, Fuchs D. Adv.Exp.Med.Biol. (2003) 527: 77-83.

 

Anemia and congestive heart failure. Schroecksnadel K, Wirleitner B, Fuchs D. Circulation (2003) 108: e41-e42.

 

Re: Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. Schroecksnadel K, Frick B, Fuchs D. J.Natl.Cancer Inst. (2003) 95: 1091.

 

Immune activation to underlie moderate hyperhomocysteinemia in stroke and dementia? Schroecksnadel K, Frick B, Fuchs D. Stroke (2003) 34: 833-844.

 

Moderate hyperhomocysteinaemia and immune activation in patients with rheumatoid arthritis. Schroecksnadel K, Frick B, Kaser S, Wirleitner B, Ledochowski M, Mur E, Herold M, Fuchs D. Clin.Chim.Acta (2003) 338: 157-164.

 

Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells. Schroecksnadel K, Frick B, Wirleitner B, Schennach H, Fuchs D. Clin.Exp.Immunol. (2003) 134: 53-56.

 

Increased degradation of tryptophan in blood of patients with rheumatoid arthritis. Schroecksnadel K, Kaser S, Ledochowski M, Neurauter G, Mur E, Herold M, Fuchs D. J.Rheumatol. (2003) 30: 1935-1939.

 

Hyperhomocysteinemia and immune activation.   Schroecksnadel K, Frick B, Winkler C, Leblhuber F, Wirleitner B, Fuchs D. Clin.Chem.Lab Med. (2003) 41: 1438-1443.

 

Daily psychosocial stressors and cyclic response patterns in urine cortisol and neopterin in a patient with systemic lupus erythematosus . Schubert C, Lampe A, Geser W, Noisternig B, Fuchs D, Konig P, Chamson E, Schussler G. Psychoneuroendocrinology (2003) 28: 459-473.

 

Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway. Steiner H, Godoy-Tundidor S, Rogatsch H, Berger AP, Fuchs D, Comuzzi B, Bartsch G, Hobisch A, Culig Z. Am.J.Pathol. (2003) 162: 655-663.

 

Urinary neopterin concentrations in patients with Balkan endemic nephropathy (BEN). Toncheva D, Galabov AS, Laich A, Atanassova S, Kamarinchev B, Dimitrov T, Fuchs D. Kidney Int. (2003) 64: 1817-1821.

 

HMG-CoA reductase inhibitors are associated with decreased serum neopterin levels in stable coronary artery disease. Walter RB, Fuchs D, Weiss G, Walter TR, Reinhart WH. Clin.Chem.Lab Med. (2003) 41: 1314-1319.

 

Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome. Wiedermann FJ, Mayr AJ, Hobisch-Hagen P, Fuchs D, Schobersberger W. J.Interferon Cytokine Res. (2003) 23: 729-736.

 

Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Wirleitner B, Neurauter G, Schrocksnadel K, Frick B, Fuchs D. Curr.Med.Chem. (2003) 10: 1581-1591.

 

Immune activation and degradation of tryptophan in coronary heart disease. Wirleitner B, Rudzite V, Neurauter G, Murr C, Kalnins U, Erglis A, Trusinskis K, Fuchs D. Eur.J.Clin.Invest (2003) 33: 550-554.

 

Induction of apoptosis in human blood T cells by 7,8-dihydroneopterin: the difference between healthy controls and patients with systemic lupus erythematosus. Wirleitner B, Obermoser G, Bock G, Neurauter G, Schennach H, Sepp N, Fuchs D. Clin.Immunol. (2003) 107: 152-159.

 

Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection. Abdulle S, Hagberg L, Svennerholm B, Fuchs D, Gisslen M. AIDS (2002) 16: 2145-2149.

 

Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects. De Milito A, Aleman S, Marenzi R, Sonnerborg A, Fuchs D, Zazzi M, Chiodi F, D F. Clin.Exp.Immunol. (2002) 127: 486-494.

 

Reduced pteridine derivatives induce apoptosis in PC12 cells. Enzinger C, Wirleitner B, Spottl N, Bock G, Fuchs D, Baier-Bitterlich G. Neurochem.Int. (2002) 41: 71-78.

 

7,8-Dihydroneopterin induces apoptosis of Jurkat T-lymphocytes via a Bcl-2-sensitive pathway. Enzinger C, Wirleitner B, Lutz C, Bock G, Tomaselli B, Baier G, Fuchs D,

Baier-Bitterlich G. Eur.J.Cell Biol. (2002) 81: 197-202.

 

Tissue transglutaminase antibody determination in celiac disease. Analysis of diagnostic specificity of anti-human IgA-type assays. Foldes-Papp Z, Demel U, Berry D, Domej W, Fuchs D, Tilz GP. J.Immunoassay Immunochem. (2002) 23: 211-227.

 

Serum folate and homocysteine levels in head and neck squamous cell carcinoma. Frick B, Schrocksnadel K, Fuchs D. Cancer (2002) 95: 2252-2253.

 

Moderate hyperhomocysteinemia and oxidative stress. Frick B, Neurauter G, Fuchs D. Kidney Int. (2002) 61: 1910.

 

Neopterin as a marker of immunostimulation: an investigation in anaesthetic workplaces. Gruber G, Lirk P, Amann A, Keller C, Schobersberger W, Hoffmann G, Fuchs D, Rieder J. Anaesthesia (2002) 57: 747-750.

 

Neopterin and 7,8-dihydroneopterin interfere with low density lipoprotein oxidation mediated by peroxynitrite and/or copper. Herpfer I, Greilberger J, Ledinski G, Widner B, Fuchs D, Jurgens G. Free Radic.Res. (2002) 36: 509-520.

 

Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. Huang A, Fuchs D, Widner B, Glover C, Henderson DC, Allen-Mersh TG. Br.J.Cancer (2002) 86: 1691-1696.

 

Depression in terminally ill patients with cancer. Huang A, Fuchs D. J.R.Soc.Med. (2002) 95: 526.

 

More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Laich A, Neurauter G, Widner B, Fuchs D. Clin.Chem. (2002) 48: 579-581.

 

Degradation of serum neopterin during daylight exposure. Laich A, Neurauter G, Wirleitner B, Fuchs D. Clin.Chim.Acta (2002) 322: 175-178.

 

Neopterin as a marker for immune system activation. Murr C, Widner B, Wirleitner B, Fuchs D. Curr.Drug Metab (2002) 3: 175-187.

 

Chronic immune stimulation may link ischemic heart disease with depression. Murr C, Ledochowski M, Fuchs D. Circulation (2002) 105: e83.

 

Is the poorer rate of survival among patients with human immunodeficiency virus infection and anemia linked to immune activation? Sarcletti M, Bitterlich W, Fuchs D, Zangerle R. J.Infect.Dis. (2002) 186: 141-142.

 

Acute cytomegalovirus infections in blood donors are indicated by increased serum neopterin concentrations. Schennach H, Hessenberger G, Mayersbach P, Schonitzer D, Fuchs D. Med.Microbiol.Immunol.(Berl) (2002) 191: 115-118.

 

Factors influencing serum neopterin concentrations in a population of blood donors. Schennach H, Murr C, Gachter E, Mayersbach P, Schonitzer D, Fuchs D. Clin.Chem. (2002) 48: 643-645.

 

Neopterin concentrations in cord blood: a single-cohort study of paired samples from 541 pregnant women and their newborns.   Schennach H, Murr C, Larcher C, Streif W, Pastner E, Zaknun D, Schonitzer D, Fuchs D. Clin.Chem. (2002) 48: 2059-2061.

 

Human parvovirus Bb19 detection in asymptomatic blood donors: association with increased neopterin concentrations. Schennach H, Lanthaler AJ, Mayersbach P, Ulmer H, Muell K, Schoenitzer D, Fuchs D, Larcher C. J.Infect.Dis. (2002) 186: 1494-1497.

 

Increased neopterin production and tryptophan degradation in advanced Parkinson’s disease. Widner B, Leblhuber F, Fuchs D. J.Neural Transm. (2002) 109: 181-189.

 

Hyperhomocysteinemia, pteridines and oxidative stress. Widner B, Enzinger C, Laich A, Wirleitner B, Fuchs D. Curr.Drug Metab (2002) 3: 225-232.

 

Moderate hyperhomocysteinaemia and immune activation in Parkinson’s disease. Widner B, Leblhuber F, Frick B, Laich A, Artner-Dworzak E, Fuchs D. J.Neural Transm. (2002) 109: 1445-1452.

 

Neopterin production, tryptophan degradation, and mental depression–what is the link? Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D. Brain Behav.Immun. (2002) 16: 590-595.

 

Monocyte-derived dendritic cells release neopterin. Wirleitner B, Reider D, Ebner S, Bock G, Widner B, Jaeger M, Schennach H, Romani N, Fuchs D. J.Leukoc.Biol. (2002) 72: 1148-1153.

 

Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Zangerle R, Widner B, Quirchmair G, Neurauter G, Sarcletti M, Fuchs D. Clin.Immunol. (2002) 104: 242-247.

 

Neopterin production in SCID mice injected with human peripheral blood mononuclear cells. Amadori A, Wirleitner B, Diez-Ruiz A, Veronesi A, Chieco-Bianchi L, Fuchs D. Immunobiology (2001) 203: 642-649.

 

Monitoring of immune activation using biochemical changes in a porcine model of cardiac arrest. Amann A, Widner B, Rieder J, Antretter H, Hoffmann G, Mayr V, Strohmenger HU, Fuchs D. Mediators.Inflamm. (2001) 10: 343-346.

 

Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals–correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels. Andersson LM, Hagberg L, Fuchs D, Svennerholm B, Gisslen M. J.Neurovirol. (2001) 7: 542-547.

 

Contraceptive choices in HIV infected and HIV at-risk adolescent females. Belzer M, Rogers AS, Camarca M, Fuchs D, Peralta L, Tucker D, Durako SJ. J.Adolesc.Health (2001) 29: 93-100.

 

[The influence of daily psychosocial stressors and associated emotions on the dynamic course of urine cortisol and urine neopterin in systemic lupus erythematosus:

Experience taken from two „integrative single-case studies“]. Christian S, Lampe A, Rumpold G, Geser W, Noisternig B, Chamson E, Schatz D, Konig P, Fuchs D, Schussler G. Z.Psychosom.Med.Psychother. (2001) 47: 58-79.

 

Influence of cytokines tumor necrosis factor-alpha and interferon-gamma on signaling cascades associated with apoptosis in rat PC12 cells. Enzinger C, Wirleitner B, Bock G, Baier-Bitterlich G, Fuchs D. Neurosci.Lett. (2001) 316: 157-160.

 

Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake? Fuchs D, Jaeger M, Widner B, Wirleitner B, Artner-Dworzak E, Leblhuber F. Clin.Chem.Lab Med. (2001) 39: 691-694.

 

Blunted erythropoietic response to anemia in multiply traumatized patients. Hobisch-Hagen P, Wiedermann F, Mayr A, Fries D, Jelkmann W, Fuchs D, Hasibeder W, Mutz N, Klingler A, Schobersberger W. Crit Care Med. (2001) 29: 743-747.

 

Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype. Hobisch A, Ramoner R, Fuchs D, Godoy-Tundidor S, Bartsch G, Klocker H, Culig Z. Clin.Cancer Res. (2001) 7: 2941-2948.

 

Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline. Lass-Florl C, Dierich MP, Fuchs D, Semenitz E, Ledochowski M. Clin.Infect.Dis. (2001) 33: E135-E136.

 

Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro. Lass-Florl C, Dierich MP, Fuchs D, Semenitz E, Jenewein I, Ledochowski M. J.Antimicrob.Chemother. (2001) 48: 775-779.

 

Homocysteine and B vitamins in dementia. Leblhuber F, Walli J, Widner B, Artner-Dworzak E, Fuchs D, Vrecko K. Am.J.Clin.Nutr. (2001) 73: 127-128.

 

Increased serum amylase and lipase in fructose malabsorbers. Ledochowski M, Murr C, Lass-Florl C, Fuchs D. Clin.Chim.Acta (2001) 311: 119-123.

 

Fructose malabsorption is associated with decreased plasma tryptophan. Ledochowski M, Widner B, Murr C, Sperner-Unterweger B, Fuchs D. Scand.J.Gastroenterol. (2001) 36: 367-371.

 

Decreased serum zinc in fructose malabsorbers. Ledochowski M, Widner B, Murr C, Fuchs D. Clin.Chem. (2001) 47: 745-747.

 

Dehydroepiandrosterone, ageing and immune activation. Ledochowski M, Murr C, Jager M, Fuchs D. Exp.Gerontol. (2001) 36: 1739-1747.

 

Inverse relationship between neopterin and immunoglobulin E. Ledochowski M, Murr C, Widner B, Fuchs D. Clin.Immunol. (2001) 98: 104-108.

 

Efficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques. Munch J, Stolte N, Fuchs D, Stahl-Hennig C, Kirchhoff F. J.Virol. (2001) 75: 10532-10536.

 

Simian immunodeficiency virus in which nef and U3 sequences do not overlap replicates efficiently in vitro and in vivo in rhesus macaques. Munch J, Adam N, Finze N, Stolte N, Stahl-Hennig C, Fuchs D, Ten Haaft P, Heeney JL, Kirchhoff F. J.Virol. (2001) 75: 8137-8146.

 

Neopterin production and tryptophan degradation in humans infected by Streptococcus pyogenes. Murr C, Gerlach D, Widner B, Dierich MP, Fuchs D. Med.Microbiol.Immunol.(Berl) (2001) 189: 161-163.

 

Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. Quigley MA, Mwinga A, Hosp M, Lisse I, Fuchs D, Porter JDH, Godfrey-Faussett P. AIDS (2001) 15: 215-222.

 

Perioperative treatment with human recombinant interferon-gamma: a randomized double-blind clinical trial. Schinkel C, Licht K, Zedler S, Schinkel S, Fuchs D, Faist E. Shock (2001) 16: 329-333.

 

Interferon-gamma modifies cytokine release in vitro by monocytes from surgical patients. Schinkel C, Licht K, Zedler S, Schinkel S, Fraunberger P, Fuchs D, Neugebauer E, Kreuzer E, Faist E. J.Trauma (2001) 50: 321-327.

 

Does disturbed homocysteine and folate metabolism in depression result from enhanced oxidative stress? Widner B, Fuchs D, Leblhuber F, Sperner-Unterweger B. J.Neurol.Neurosurg.Psychiatry (2001) 70: 419.

 

Induction of apoptosis by 7,8-dihydroneopterin: involvement of radical formation. Wirleitner B, Czaputa R, Oettl K, Bock G, Widner B, Reibnegger G, Baier G, Fuchs D, Baier-Bitterlich G. Immunobiology (2001) 203: 629-641.

 

Aqueous extracts of Crinum latifolium (L.) and Camellia sinensis show immunomodulatory properties in human peripheral blood mononuclear cells. Zvetkova E, Wirleitner B, Tram NT, Schennach H, Fuchs D. Int.Immunopharmacol. (2001) 1: 2143-2150.

 

Simian immunodeficiency virus containing mutations in N-terminal tyrosine residues and in the PxxP motif in Nef replicates efficiently in rhesus macaques. Carl S, Iafrate AJ, Lang SM, Stolte N, Stahl-Hennig C, Matz-Rensing K, Fuchs D, Skowronski J, Kirchhoff F. J.Virol. (2000) 74: 4155-4164.

 

Histamine suppresses neopterin production in the human myelomonocytoma cell line THP-1. Gruber A, Murr C, Wirleitner B, Werner-Felmayer G, Fuchs D. Immunol.Lett. (2000) 72: 133-136.

 

Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients. Hagberg L, Fuchs D, Rosengren L, Gisslen M. J.Neuroimmunol. (2000) 102: 51-55.

 

Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. Hobisch A, Rogatsch H, Hittmair A, Fuchs D, Bartsch G, Jr., Klocker H, Bartsch G, Culig Z. J.Pathol. (2000) 191: 239-244.

 

An evaluation of low-cost progression markers in HIV-1 seropositive Zambians. Hosp M, Lisse IM, Quigley M, Mwinga AM, Godfrey-Faussett P, Porter JD, Luo N, Pobee J, Wachter H, McAdam KP, Fuchs D. HIV.Med. (2000) 1: 125-127.

 

Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus WBC-reduced blood transfusions in patients undergoing arthroplasty. II.

 

Activation of T cells, macrophages, and cell-mediated lympholysis. Innerhofer P, Tilz G, Fuchs D, Luz G, Hobisch-Hagen P, Schobersberger W, Nussbaumer W, Lochs A, Irschick E. Transfusion (2000) 40: 821-827.

 

Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostate. Ischia R, Hobisch A, Bauer R, Weiss U, Gasser RW, Horninger W, Bartsch G, Jr., Fuchs D, Bartsch G, Winkler H, Klocker H, Fischer-Colbrie R, Culig Z. J.Urol. (2000) 163: 1161-1164.

 

Comment: treatment of hyperhomocysteinemia with folic acid. Leblhuber F, Walli J, Artner-Dworzak E, Vrecko K, Fuchs D. Ann.Pharmacother. (2000) 34: 1207-1208.

 

Hyperhomocysteinemia in dementia. Leblhuber F, Walli J, Artner-Dworzak E, Vrecko K, Widner B, Reibnegger G, Fuchs D. J.Neural Transm. (2000) 107: 1469-1474.

 

The role of psychological and biological factors in postinfective gut dysfunction. Ledochowski M, Propst T, Fuchs D. Gut (2000) 46: 140-141.

 

Homocysteine and heart disease in Indian Asians. Ledochowski M, Bernhard W, Fuchs D. Lancet (2000) 355: 2249.

 

Helicobacter pylori and chronic immune activation. Ledochowski M, Widner B, Fuchs D. Am.Heart J. (2000) 139: 925-926.

 

Carbohydrate malabsorption syndromes and early signs of mental depression in females. Ledochowski M, Widner B, Sperner-Unterweger B, Propst T, Vogel W, Fuchs D. Dig.Dis.Sci. (2000) 45: 1255-1259.

 

Fructose- and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Ledochowski M, Widner B, Bair H, Probst T, Fuchs D. Scand.J.Gastroenterol. (2000) 35: 1048-1052.

 

Central nervous system activation of the indoleamine-2,3-dioxygenase pathway in human T cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. Maloney EM, St Claire MO, Widner B, Werner ER, Fuchs D. J.Infect.Dis. (2000) 181: 2037-2040.

 

Exogenous neopterin causes cardiac contractile dysfunction in the isolated perfused rat heart. Margreiter J, Schlager A, Balogh A, Maier H, Balogh D, Lindner KH, Fuchs D, Schobersberger W. J.Mol.Cell Cardiol. (2000) 32: 1265-1274.

 

Immune reaction links disease progression in cancer patients with depression. Murr C, Widner B, Sperner-Unterweger B, Ledochowski M, Schubert C, Fuchs D. Med.Hypotheses (2000) 55: 137-140.

 

[Neopterin: new immunological marker of autoimmune rheumatic disease]. Nasonov EL, Samsonov MI, Tilz G, Fuchs D. Klin.Med.(Mosk) (2000) 78: 43-46.

 

Soluble adhesion molecules in rheumatoid arthritis. Nassonov EL, Samsonov MY, Chichasova NV, Nikiphorova EL, Tilz GP, Demel U, Widner B, Fuchs D.

Rheumatology.(Oxford) (2000) 39: 808-810.

 

Neopterin: a prognostic variable in operations for lung cancer. Prommegger R, Widner B, Murr C, Unger A, Fuchs D, Salzer GM. Ann.Thorac.Surg. (2000) 70: 1861-1864.

 

Homozygosity for a conserved Mhc class II DQ-DRB haplotype is associated with rapid disease progression in simian immunodeficiency virus-infected macaques: results from a prospective study. Sauermann U, Stahl-Hennig C, Stolte N, Muhl T, Krawczak M, Spring M, Fuchs D, Kaup FJ, Hunsmann G, Sopper S. J.Infect.Dis. (2000) 182: 716-724.

 

Increase in immune activation, vascular endothelial growth factor and erythropoietin after an ultramarathon run at moderate altitude. Schobersberger W, Hobisch-Hagen P, Fries D, Wiedermann F, Rieder-Scharinger J, Villiger B, Frey W, Herold M, Fuchs D, Jelkmann W. Immunobiology (2000) 201: 611-620.

 

Predictive value of cytokines during acute severe pancreatitis. Schobersberger W, Wiedermann F, Tilz GP, Fuchs D. Crit Care Med. (2000) 28: 2673-2674.

 

Inflammation marker 7,8-dihydroneopterin induces apoptosis of neurons and glial cells: a potential contribution to neurodegenerative processes. Speth C, Stockl G, Fuchs D, Wirleitner B, Widner B, Wurzner R, Mohsenipour I, Lass-Florl C, Dierich MP. Immunobiology (2000) 202: 460-476.

 

Reduced pteridine derivatives induce apoptosis in human neuronal NT2/HNT cells. Spottl N, Wirleitner B, Bock G, Widner B, Fuchs D, Baier-Bitterlich G. Immunobiology (2000) 201: 478-491.

 

Tryptophan degradation and immune activation in Alzheimer’s disease. Widner B, Leblhuber F, Walli J, Tilz GP, Demel U, Fuchs D. J.Neural Transm. (2000) 107: 343-353.

 

Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences. Widner B, Ledochowski M, Fuchs D. Curr.Drug Metab (2000) 1: 193-204.

 

Enhanced tryptophan degradation in systemic lupus erythematosus. Widner B, Sepp N, Kowald E, Ortner U, Wirleitner B, Fritsch P, Baier-Bitterlich G, Fuchs D. Immunobiology (2000) 201: 621-630.

 

Sleep disturbances and tryptophan in patients with Alzheimer’s disease. Widner B, Ledochowski M, Fuchs D. Lancet (2000) 355: 755-756.

 

Cellular immune activation, neopterin production, tryptophan degradation and the development of immunodeficiency. Widner B, Wirleitner B, Baier-Bitterlich G, Weiss G, Fuchs D. Arch.Immunol.Ther.Exp.(Warsz.) (2000) 48: 251-258.

 

Tryptophan degradation to control T-cell responsiveness. Widner B, Weiss G, Fuchs D. Immunol.Today (2000) 21: 250.

 

Oxidation of 7,8-dihydroneopterin by hypochlorous acid yields neopterin. Widner B, Mayr C, Wirleitner B, Fuchs D. Biochem.Biophys.Res.Commun. (2000) 275: 307-311.

 

Increased cerebrospinal fluid protein tau concentration in neuro-AIDS. Andersson L, Blennow K, Fuchs D, Svennerholm B, Gisslen M. J.Neurol.Sci. (1999) 171: 92-96.

 

The acidic region and conserved putative protein kinase C phosphorylation site in Nef are important for SIV replication in rhesus macaques. Carl S, Iafrate AJ, Lang SM, Stahl-Hennig C, Kuhn EM, Fuchs D, Matz-Rensing K, Ten Haaft P, Heeney JL, Skowronski J, Kirchhoff F. Virology (1999) 257: 138-155.

 

Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. Gisslen M, Fuchs D, Svennerholm B, Hagberg L. J.Acquir.Immune.Defic.Syndr. (1999) 21: 271-276.

 

Neopterin-induced expression of intercellular adhesion molecule-1 (ICAM-1) in type II-like alveolar epithelial cells. Hoffmann G, Rieder J, Smolny M, Seibel M, Wirleitner B, Fuchs D, Schobersberger W. Clin.Exp.Immunol. (1999) 118: 435-440.

 

The human immunodeficiency virus type 1 nef gene can to a large extent replace simian immunodeficiency virus nef in vivo. Kirchhoff F, Munch J, Carl S, Stolte N, Matz-Rensing K, Fuchs D, Haaft PT, Heeney JL, Swigut T, Skowronski J, Stahl-Hennig C. J.Virol. (1999) 73: 8371-8383.

 

Increased serum neopterin concentrations in patients with Alzheimer’s disease. Leblhuber F, Walli J, Demel U, Tilz GP, Widner B, Fuchs D. Clin.Chem.Lab Med. (1999) 37: 429-431.

 

Association between insulin resistance, body mass and neopterin concentrations. Ledochowski M, Murr C, Widner B, Fuchs D. Clin.Chim.Acta (1999) 282: 115-123.

 

Fructose malabsorption is associated with lower plasma folic acid concentrations in middle-aged subjects. Ledochowski M, Uberall F, Propst T, Fuchs D. Clin.Chem. (1999) 45: 2013-2014.

 

Fructose malabsorption is associated with decreased plasma tryptophan. Ledochowski M, Widner B, Propst-Braunsteiner T, Vogel W, Sperner-Unterweger B, Fuchs D. Adv.Exp.Med.Biol. (1999) 467: 73-78.

 

Obesity and cytokines. Ledochowski M, Murr C, Fuchs D. Int.J.Obes.Relat Metab Disord. (1999) 23: 1104.

 

Kynurenine and neopterin in chronic glomerulonephritis. Martinsons A, Rudzite V, Groma V, Bratslavska O, Widner B, Fuchs D. Adv.Exp.Med.Biol. (1999) 467: 579-586.

 

Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Murr C, Fuith LC, Widner B, Wirleitner B, Baier-Bitterlich G, Fuchs D. Anticancer Res. (1999) 19: 1721-1728.

 

Neopterin is an independent prognostic variable in females with breast cancer. Murr C, Bergant A, Widschwendter M, Heim K, Schrocksnadel H, Fuchs D. Clin.Chem. (1999) 45: 1998-2004.

 

[Soluble adhesion molecules (P-selectin, ICAM-1 and ICAM-3) in rheumatoid arthritis]. Nasonov EL, Samsonov MI, Tilz GP, Nikiforova EL, Chichasova NV, Imametdinova GR, Ilich-Stoianovich O, Baranov AA, Fuchs D, Nasonova VA. Ter.Arkh. (1999) 71: 17-20.

 

Intra-nasal infection of macaques with Yellow Fever (YF) vaccine strain 17D: a novel and economical approach for YF vaccination in man. Niedrig M, Stolte N, Fuchs D, Hunsmann G, Stahl-Hennig C. Vaccine (1999) 17: 1206-1210.

 

Formation of oxygen radicals in solutions of 7,8-dihydroneopterin. Oettl K, Wirleitner B, Baier-Bitterlich G, Grammer T, Fuchs D, Reibnegger G. Biochem.Biophys.Res.Commun. (1999) 264: 262-267.

 

Effects of neopterin and 7,8-dihydroneopterin on hypoxia-induced renal erythropoietin production. Pagel H, Fandrey J, Schobersberger W, Fuchs D, Jelkmann W. Eur.J.Haematol. (1999) 62: 341-345.

 

Daily psychosocial stressors interfere with the dynamics of urine neopterin in a patient with systemic lupus erythematosus: an integrative single-case study. Schubert C, Lampe A, Rumpold G, Fuchs D, Konig P, Chamson E, Schussler G. Psychosom.Med. (1999) 61: 876-882.

 

Neopterin derivatives modulate toxicity of reactive species on Escherichia coli. Wede I, Widner B, Fuchs D. Free Radic.Res. (1999) 31: 381-388.

 

Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Weiss G, Murr C, Zoller H, Haun M, Widner B, Ludescher C, Fuchs D. Clin.Exp.Immunol. (1999) 116: 435-440.

 

Degradation of tryptophan in patients with systemic lupus erythematosus. Widner B, Sepp N, Kowald E, Kind S, Schmuth M, Fuchs D. Adv.Exp.Med.Biol. (1999) 467: 571-577.

 

Degradation of tryptophan in neurodegenerative disorders . Widner B, Leblhuber F, Walli J, Tilz GP, Demel U, Fuchs D. Adv.Exp.Med.Biol. (1999) 467: 133-138.

 

Abnormal potassium-channel function in platelets in Alzheimer’s disease. Widner B, Leblhuber F, Fuchs D. Lancet (1999) 353: 325-326.

 

An HPLC method to determine tryptophan and kynurenine in serum simultaneously. Widner B, Werner ER, Schennach H, Fuchs D. Adv.Exp.Med.Biol. (1999) 467: 827-832.

 

Neurological efficacy of stavudine, zidovudine, and lamivudine. Gisslen M, Svennerholm B, Fuchs D, Hagberg L. Lancet (1998) 352: 402-403.

 

Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study. Gisslen M, Hagberg L, Fuchs D, Norkrans G, Svennerholm B.

J.Acquir.Immune.Defic.Syndr.Hum.Retrovirol. (1998) 17: 291-295.

 

Neopterin-induced tumor necrosis factor-alpha synthesis in vascular smooth muscle cells in vitro. Hoffmann G, Frede S, Kenn S, Smolny M, Wachter H, Fuchs D, Grote J, Rieder J, Schobersberger W. Int.Arch.Allergy Immunol. (1998) 116: 240-245.

 

Neopterin induces nitric oxide-dependent apoptosis in rat vascular smooth muscle cells. Hoffmann G, Kenn S, Wirleitner B, Deetjen C, Frede S, Smolny M, Rieder J, Fuchs D, Baier-Bitterlich G, Schobersberger W. Immunobiology (1998) 199: 63-73.

 

Neopterin levels and pulmonary tuberculosis in infants. Horak E, Gassner I, Solder B, Wachter H, Fuchs D. Lung (1998) 176: 337-344.

 

Neopterin plasma concentrations predict the course of severe acute pancreatitis. Kaufmann P, Tilz GP, Demel U, Wachter H, Kreijs GJ, Fuchs D. Clin.Chem.Lab Med. (1998) 36: 29-34.

 

[Systemic changes of the immune system in patients with Alzheimer’s dementia]. Leblhuber F, Walli J, Tilz GP, Wachter H, Fuchs D. Dtsch.Med.Wochenschr. (1998) 123: 787-791.

 

Activated immune system in patients with Huntington’s disease. Leblhuber F, Walli J, Jellinger K, Tilz GP, Widner B, Laccone F, Fuchs D. Clin.Chem.Lab Med. (1998) 36: 747-750.

 

Fructose malabsorption is associated with early signs of mental depression. Ledochowski M, Sperner-Unterweger B, Widner B, Fuchs D. Eur.J.Med.Res. (1998) 3: 295-298.

 

Lactose malabsorption is associated with early signs of mental depression in females: a preliminary report. Ledochowski M, Sperner-Unterweger B, Fuchs D. Dig.Dis.Sci. (1998) 43: 2513-2517.

 

Neopterin as a prognostic parameter in patients with squamous-cell carcinomas of the oral cavity. Murr C, Berchtold J, Norer B, Waldhart E, Wachter H, Fuchs D. Int.J.Cancer (1998) 79: 476-480.

 

A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers protects rhesus macaques against productive infection with SIVmac32H. Petry H, Stahl-Hennig C, Dittmer U, Jones D, Farrar G, Wachter H, Fuchs D, Nisslein T, Jurkiewicz E, Hunsmann G, Luke W. AIDS (1998) 12: 329-330.

 

Prechallenge high neutralizing antibodies and long-lasting immune reactivity to gp41 correlate with protection of rhesus monkeys against productive simian immunodeficiency virus infection or disease development. Petry H, Dittmer U, Jones D, Farrar G, Wachter H, Fuchs D, Nisslein T, Jurkiewicz E, Hunsmann G, Stahl-Hennig C, Luke W. J.Acquir.Immune.Defic.Syndr.Hum.Retrovirol. (1998) 19: 441-450.

 

The activated immune system and the renin-angiotensin-aldosterone system in congestive heart failure. Samsonov M, Lopatin J, Tilz GP, Artner-Dworzak E, Nassonov E, Mareev V, Belenkov J, Wachter H, Fuchs D. J.Intern.Med. (1998) 243: 93-98.

 

Serum neopterin, beta2-microglobulin, soluble interleukin-2 receptors, and immunoglobulin levels in healthy adolescents. Satoh T, Brown LM, Blattner WA, Maloney EM, Kurman CC, Nelson DL, Fuchs D, Wachter H, Tollerud DJ. Clin.Immunol.Immunopathol. (1998) 88: 176-182.

 

Association between chronic hepatitis C virus infection and increased neopterin concentrations in blood donations. Schennach H, Schoenitzer D, Fuchs D. Clin.Chem. (1998) 44: 2225-2226.

 

Suppression of viral replication in a long-term nonprogressing rhesus macaque experimentally infected with pathogenic simian immunodeficiency virus (SIV). Spring M, Stahl-Hennig C, Nisslein T, Locher C, Fuchs D, Bodemer W, Hunsmann G, Dittmer U. Clin.Immunol.Immunopathol. (1998) 87: 101-105.

 

Diatomaceous earth lowers blood cholesterol concentrations. Wachter H, Lechleitner M, Artner-Dworzak E, Hausen A, Jarosch E, Widner B, Patsch J, Pfeiffer K, Fuchs D. Eur.J.Med.Res. (1998) 3: 211-215.

 

Inhibition of xanthine oxidase by pterins. Wede I, Altindag ZZ, Widner B, Wachter H, Fuchs D. Free Radic.Res. (1998) 29: 331-338.

 

The immunobiology of zinc and the kidney. Weiss G, Widner B, Zoller H, Fuchs D. Immunol.Today (1998) 19: 193-194.

 

Immune response and iron metabolism. Weiss G, Widner B, Zoller H, Schobersberger W, Fuchs D. Br.J.Anaesth. (1998) 81 Suppl 1: 6-9.

 

Neopterin derivatives modulate the nitration of tyrosine by peroxynitrite. Widner B, Baier-Bitterlich G, Wede I, Wirleitner B, Fuchs D. Biochem.Biophys.Res.Commun. (1998) 248: 341-346.

 

Determination of silicon in urine by inductive coupled plasma-optical emission spectroscopy. Widner B, Mirlach A, Hausen A, Jenewein I, Jenewein D, Dierich MP, Wachter H, Fuchs D. Clin.Chim.Acta (1998) 277: 51-63.

 

7,8-Dihydroneopterin-induced apoptosis in Jurkat T lymphocytes: a comparison with anti-Fas- and hydrogen peroxide-mediated cell death. Wirleitner B, Baier-Bitterlich G, Bock G, Widner B, Fuchs D. Biochem.Pharmacol. (1998) 56: 1181-1187.

 

Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals. Zangerle R, Steinhuber S, Sarcletti M, Dierich MP, Wachter H, Fuchs D, Most J. Int.Arch.Allergy Immunol. (1998) 116: 228-239.

 

Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer. Zeimet AG, Widschwendter M, Knabbe C, Fuchs D, Herold M, Muller-Holzner E, Daxenbichler G, Offner FA, Dapunt O, Marth C. J.Clin.Oncol. (1998) 16: 1861-1868.

 

Colchicine derivatives inhibit neopterin production in human peripheral blood mononuclear cells (PBMC). Altindag ZZ, Werner-Felmayer G, Sahin G, Wachter H, Fuchs D. Clin.Exp.Immunol. (1997) 107: 574-577.

 

Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection. Baier-Bitterlich G, Fuchs D, Wachter H. Biochem.Pharmacol. (1997) 53: 755-763.

 

trans-Activation of the HIV type 1 promoter by 7,8-dihydroneopterin in vitro. Baier-Bitterlich G, Fuchs D, Zangerle R, Baeuerle PA, Werner ER, Fresser F, Uberall F, Baier G, Wachter H. AIDS Res.Hum.Retroviruses (1997) 13: 173-178.

 

[Serum neopterin in hemorrhagic vasculitis]. Baranov AA, Samsonov MI, Nasonov EL, Vachter H, Shilkina NP, Fuchs D, Salozhin KV. Klin.Med.(Mosk) (1997) 75: 34-36.

 

Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2. Gundlach BR, Linhart H, Dittmer U, Sopper S, Reiprich S, Fuchs D, Fleckenstein B, Hunsmann G, Stahl-Hennig C, Uberla K. J.Virol. (1997) 71: 2225-2232.

 

Neopterin, beta 2-microglobulin, and acute phase proteins in HIV-1-seropositive and -seronegative Zambian patients with tuberculosis. Hosp M, Elliott AM, Raynes JG, Mwinga AG, Luo N, Zangerle R, Pobee JO, Wachter H, Dierich MP, McAdam KP, Fuchs D. Lung (1997) 175: 265-275.

 

Enteropathy in Zambians with HIV related diarrhoea: regression modelling of potential determinants of mucosal damage. Kelly P, Davies SE, Mandanda B, Veitch A, McPhail G, Zulu I, Drobniewski F, Fuchs D, Summerbell C, Luo NP, Pobee JO, Farthing MJ. Gut (1997) 41: 811-816.

 

Increased peripheral mononuclear cells expression of adhesion molecules in alcoholic cirrhosis: its relation to immune activation. Luna-Casado L, Diez-Ruiz A, Gutierrez-Gea F, Santos-Perez JL, Rico-Irles J, Wachter H, Fuchs D. J.Hepatol. (1997) 27: 477-483.

 

Temporal variability in immunological parameters: peripheral blood mononuclear cell subsets, serum immunoglobulins, and soluble markers of immune system activation. Maloney EM, Brown LM, Kurman CC, Fuchs D, Nelson DL, Wachter H, Blattner WA, Tollerud DJ. J.Clin.Lab Anal. (1997) 11: 190-195.

 

Streptococcal erythrogenic toxins induce tryptophan degradation in human peripheral blood mononuclear cells. Murr C, Widner B, Gerlach D, Werner-Felmayer G, Dierich MP, Wachter H, Fuchs D. Int.Arch.Allergy Immunol. (1997) 114: 224-228.

 

[Neopterin: marker of cellular immunity activation in idiopathic inflammatory myopathy]. Nasonov EL, Samsonov MI, Shtutman VZ, Gekht BM, Gurkina GT, Tilz GP, Guseva NG, Fuchs D, Wachter H. Klin.Med.(Mosk) (1997) 75: 47-51.

 

Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener’s granulomatosis. Nassonov EL, Samsonov MY, Tilz GP, Beketova TV, Semenkova EN, Baranov A, Wachter H, Fuchs D. J.Rheumatol. (1997) 24: 666-670.

 

Erythropoietin response is blunted in critically ill patients. Navarro JF, Mora-Fernandez C, Hoffmann G, Fuchs D. Intensive Care Med. (1997) 23: 920-921.

 

Elevated serum levels of neopterin in adult patients with polymyositis/dermatomyositis. Samsonov MY, Nassonov EL, Tilz GP, Geht BM, Demel U, Gurkina GT, Shtutman VZ, Guseva AG, Wachter H, Fuchs D. Br.J.Rheumatol. (1997) 36: 656-660.

 

Blood donations and viruses. Schennach H, Schonitzer D, Wachter H, Fuchs D. Lancet (1997) 349: 1327-1328.

 

Erythropoietin response and cytokines in critically ill patients. Schobersberger W, Hobisch-Hagen P, Hoffmann G, Fuchs D. Intensive Care Med. (1997) 23: 920.

 

Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. Clin.Chem. (1997) 43: 2424-2426.

 

Neopterin derivatives to activate NF-kappa B. Wirleitner B, Baier-Bitterlich G, Hoffmann G, Schobersberger W, Wachter H, Fuchs D. Free Radic.Biol.Med. (1997) 23: 177-179.

 

Correlation of ribonucleic acid polymerase chain reaction, acid dissociated p24 antigen, and neopterin with progression of disease. A retrospective, longitudinal study of vertically acquired human immunodeficiency virus type 1 infection in children. Zaknun D, Orav J, Kornegay J, al Attar I, Fuchs D, Zaknun J, Wachter H, Chatis P, Burchett SK, McIntosh K. J.Pediatr. (1997) 130: 898-905.

 

Tumor-associated antigen 90K activates myelomonocytic cell line THP-1. Altindag ZZ, Marth C, Werner-Felmayer G, Natoli C, Zeimet AG, Wachter H, Iacobelli S, Fuchs D. Cancer Lett. (1996) 107: 143-148.

 

Role of 7,8-dihydroneopterin in T-cell apoptosis and HTLV-1 transcription in vitro. Baier-Bitterlich G, Baier G, Fuchs D, Bock G, Hausen A, Utermann G, Pavelka M, Wachter H. Oncogene (1996) 13: 2281-2285.

 

Oxidative stress and apoptosis in HIV infection. Baier-Bitterlich G, Wachter H, Fuchs D. Science (1996) 271: 582-583.

 

7,8-Dihydroneopterin upregulates interferon-gamma promoter in T cells. Baier-Bitterlich G, Fuchs D, Wachter H. Immunobiology (1996) 196: 350-355.

 

Interferon-gamma and management of infectious diseases. Baier-Bitterlich G, Wachter H, Fuchs D. Ann.Intern.Med. (1996) 124: 1095-1096.

 

Role of neopterin and 7,8-dihydroneopterin in human immunodeficiency virus infection: marker for disease progression and pathogenic link . Baier-Bitterlich G, Wachter H, Fuchs D. J.Acquir.Immune.Defic.Syndr.Hum.Retrovirol. (1996) 13: 184-193.

 

Activated cellular immunity and decreased serum tryptophan in healthy pregnancy. Fuchs D, Schrocksnadel H, Baier-Bitterlich G, Dapunt O, Wachter H. Adv.Exp.Med.Biol. (1996) 398: 149-153.

 

Increase of tryptophan in serum and in cerebrospinal fluid of patients with HIV infection during zidovudine therapy. Fuchs D, Gisslen M, Larsson M, Norkrans G, Hagberg L, Wachter H. Adv.Exp.Med.Biol. (1996) 398: 131-134.

 

Neopterin concentrations in vaginal secretions. Fuith LC, Czarnecki M, Wachter H, Fuchs D. Clin.Chem. (1996) 42: 1495-1497.

 

Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-

cell leukemia/lymphoma. Giusti RM, Maloney EM, Hanchard B, Morgan OS, Steinberg SM, Wachter H, Williams E, Cranston B, Fuchs D, Manns A. Cancer

Epidemiol.Biomarkers Prev. (1996) 5: 699-704.

 

Intrathecal immunoactivation in patients with HIV-1 infection is reduced by zidovudine but not by didanosine. Hagberg L, Norkrans G, Gisslen M, Wachter H, Fuchs D, Svennerholm B. Scand.J.Infect.Dis. (1996) 28: 329-333.

 

Neopterin activates transcription factor nuclear factor-kappa B in vascular smooth muscle cells. Hoffmann G, Schobersberger W, Frede S, Pelzer L, Fandrey J, Wachter H, Fuchs D, Grote J. FEBS Lett. (1996) 391: 181-184.

 

Systemic immune activation as a potential determinant of wasting in Zambians with HIV-related diarrhoea. Kelly P, Summerbell C, Ngwenya B, Mandanda B, Hosp M, Fuchs D, Wachter H, Luo NP, Pobee JO, Farthing MJ. QJM. (1996) 89: 831-837.

 

Increased serum neopterin concentrations in a patient with Creutzfeldt-Jakob disease. Leblhuber F, Walli J, Tilz GP, Jellinger K, Wachter H, Fuchs D. J.Neurol.Neurosurg.Psychiatry (1996) 61: 211-212.

 

[Role of the immune parameter neopterin in adnexitis]. Marth C, Windbichler G, Fuchs D, Zeimet AG, Wachter H, Dapunt O. Zentralbl.Gynakol. (1996) 118: 164-168.

 

Effects of neopterin-derivatives on H2O2-induced luminol chemiluminescence: mechanistic aspects. Murr C, Baier-Bitterlich G, Fuchs D, Werner ER, Esterbauer H, Pfleiderer W, Wachter H. Free Radic.Biol.Med. (1996) 21: 449-456.

 

Streptococcal erythrogenic toxins induce neopterin formation in human peripheral blood mononuclear cells but not in the human myelomonocytoma cell line THP-1. Murr C, Baier-Bitterlich G, Fuchs D, Gerlach D, Werner-Felmayer G, Dierich MP, Wachter H. Immunobiology (1996) 195: 314-322.

 

[Activation of cellular immunity in Wegener’s granulomatosis: a study of neopterin, interleukin-2 receptors and tumor necrosis factor]. Nasonov EL, Samsonov MI, Tilz GP, Beketova TV, Semenkova EN, Mukhin NA, Baranov AA, Wachter H, Fuchs D. Ter.Arkh. (1996) 68: 67-70.

 

[Activation of cellular immunity in acute rheumatic fever: clinical and pathogenetic significance]. Nasonov EL, Samsonov MI, Tilz GP, Pisklakov VP, Dzhuzenova B, Nasonova VA, Wachter H, Fuchs D. Vestn.Ross.Akad.Med.Nauk (1996) 41-44.

 

Serum tryptophan, kynurenine, and neopterin in patients with Guillain-Barre-syndrome (GBS) and multiple sclerosis (MS). Rudzite V, Berzinsh J, Grivane I, Fuchs D, Baier-Bitterlich G, Wachter H. Adv.Exp.Med.Biol. (1996) 398: 183-187.

 

Kynurenine and pteridines in changes of membrane fluidity. Rudzite V, Jurika E, Fuchs D, Baier-Bitterlich G, Wachter H. Adv.Exp.Med.Biol. (1996) 398: 255-261.

 

Serum-soluble interleukin-2 receptor, neopterin levels, and severity of dilated cardiomyopathy. Samsonov M, Wachter H, Fuchs D. Circulation (1996) 93: 1255-1256.

 

T-cell activation, expression of adhesion molecules and response to ethanol in alcoholic cirrhosis. Santos-Perez JL, Diez-Ruiz A, Luna-Casado L, Soto-Mas JA, Wachter H, Fuchs D, Gutierrez-Gea F. Immunol.Lett. (1996) 50: 179-183.

 

Neopterin and 7,8-dihydroneopterin induce apoptosis in the rat alveolar epithelial cell line L2. Schobersberger W, Hoffmann G, Hobisch-Hagen P, Bock G, Volkl H, Baier-Bitterlich G, Wirleitner B, Wachter H, Fuchs D. FEBS Lett. (1996) 397: 263-268.

 

Decreased plasma tryptophan in pregnancy. Schrocksnadel H, Baier-Bitterlich G, Dapunt O, Wachter H, Fuchs D. Obstet.Gynecol. (1996) 88: 47-50.

 

Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion. Stahl-Hennig C, Dittmer U, Nisslein T, Pekrun K, Petry H, Jurkiewicz E, Fuchs D, Wachter H, Rud EW, Hunsmann G. Immunol.Lett. (1996) 51: 129-135.

 

Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. Stahl-Hennig C, Dittmer U, Nisslein T, Petry H, Jurkiewicz E, Fuchs D, Wachter H, Matz-Rensing K, Kuhn EM, Kaup FJ, Rud EW, Hunsmann G. J.Gen.Virol. (1996) 77 ( Pt 12): 2969-2981.

 

Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer. Zeimet AG, Natoli C, Herold M, Fuchs D, Windbichler G, Daxenbichler G, Iacobelli S, Dapunt O, Marth C. Int.J.Cancer (1996) 68: 34-38.

 

[Immunostimulating protein 90K in ovarian carcinoma]. Zeimet AG, Marth C, Fuchs D, Herold M, Widschwendter M, Daxenbichler G, Iacobelli S, Dapunt O. Gynakol.Geburtshilfliche Rundsch. (1996) 36: 44-45.

 

Effect of neopterin and 7,8-dihydroneopterin on tumor necrosis factor-alpha induced programmed cell death. Baier-Bitterlich G, Fuchs D, Murr C, Reibnegger G, Werner-Felmayer G, Sgonc R, Bock G, Dierich MP, Wachter H. FEBS Lett. (1995) 364: 234-238.

 

Urinary neopterin excretion in patients with squamous carcinoma of the oral cavity. Berchtold J, Murr C, Norer B, Waldhart E, Wachter H, Fuchs D. Cancer Lett. (1995) 95: 227-232.

 

Neopterin and soluble tumor necrosis factor receptor type I in alcohol-induced cirrhosis. Diez-Ruiz A, Tilz GP, Gutierrez-Gea F, Gil-Extremera B, Murr C, Wachter H, Fuchs D. Hepatology (1995) 21: 976-978.

 

Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Eur.J.Haematol. (1995) 54: 1-8.

 

Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge. Dittmer U, Stahl-Hennig C, Coulibaly C, Nisslein T, Luke W, Fuchs D, Bodemer W, Petry H, Hunsmann G. J.Gen.Virol. (1995) 76 ( Pt 6): 1307-1315.

 

Assessment of dissociative identity disorder with the Million Clinical Multiaxial Inventory-II. Ellason JW, Ross CA, Fuchs DL. Psychol.Rep. (1995) 76: 895-905.

 

Conformational investigation of the cofactor (6R,1’R,2’S-)-5,6,7,8-tetrahydrobiopterin. Estelberger W, Fuchs D, Murr C, Wachter H, Reibnegger G. Biochim.Biophys.Acta (1995) 1249: 23-28.

 

Nitric oxide and AIDS dementia. Fuchs D, Baier-Bitterlich G, Wachter H. N.Engl.J.Med. (1995) 333: 521-522.

 

Human immunodeficiency virus infection and porphyria cutanea tarda. Fuchs D, Baier-Bitterlich G, Wachter H. Clin.Infect.Dis. (1995) 21: 1530-1531.

 

[Neopterin as an immunodiagnostic parameter]. Fuchs D, Baier-Bitterlich G, Hausen A, Murr C, Weiss G, Werner ER, Werner-Felmayer G, Reibnegger G. Dtsch.Med.Wochenschr. (1995) 120: 567-570.

 

vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. Hoch J, Lang SM, Weeger M, Stahl-Hennig C, Coulibaly C, Dittmer U, Hunsmann G, Fuchs D, Muller J, Sopper S, . J.Virol. (1995) 69: 4807-4813.

 

Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress. Kim C, Schinkel C, Fuchs D, Stadler J, Walz A, Zedler S, von Donnersmarck GH, Faist E. Arch.Surg. (1995) 130: 1330-1336.

 

Predictive value of urinary neopterin in patients with lung cancer. Kronberger P, Weiss G, Tschmelitsch J, Fuchs D, Salzer GM, Wachter H, Reibnegger G. Eur.J.Clin.Chem.Clin.Biochem. (1995) 33: 831-837.

 

Serum neopterin concentrations in Wegener’s granulomatosis correlate with vasculitis activity. Nassonov E, Samsonov M, Beketova T, Semenkova L, Wachter H, Fuchs D. Clin.Exp.Rheumatol. (1995) 13: 353-356.

 

Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection. Petry H, Dittmer U, Stahl-Hennig C, Coulibaly C, Makoschey B, Fuchs D, Wachter H, Tolle T, Morys-Wortmann C, Kaup FJ, . J.Virol. (1995) 69: 1564-1574.

 

Effects of pteridines on luminol-dependent chemiluminescence induced by chloramine-T. Reibnegger G, Fuchs D, Murr C, Dierich MP, Pfleiderer W, Wachter H. Free Radic.Biol.Med. (1995) 18: 515-523.

 

Serum-soluble receptors for tumor necrosis factor-alpha and interleukin-2, and neopterin in acute rheumatic fever. Samsonov MY, Tilz GP, Pisklakov VP, Reibnegger G, Nassonov EL, Nassonova VA, Wachter H, Fuchs D. Clin.Immunol.Immunopathol. (1995) 74: 31-34.

 

Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Samsonov MY, Tilz GP, Egorova O, Reibnegger G, Balabanova RM, Nassonov EL, Nassonova VA, Wachter H, Fuchs D. Lupus (1995) 4: 29-32.

 

Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells. Schobersberger W, Hoffmann G, Grote J, Wachter H, Fuchs D. FEBS Lett. (1995) 377: 461-464.

 

Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels. Strickler HD, Escoffery C, Rattray C, Fuchs D, Wachter H, Manns A, Schiffman MH, Cranston B, Hanchard B, Blattner WA. Cancer Epidemiol.Biomarkers Prev. (1995) 4: 295-298.

 

Longitudinal immunological follow-up of HIV infected haemophiliacs in Hungary. Ujhelyi E, Krall G, Zimonyl I, Banhegyi D, Hollan SR, Horvath A, Fuchs D, Wachter H, Berkessy E, Fust G. Acta Microbiol.Immunol.Hung. (1995) 42: 189-198.

 

Linkage of cell-mediated immunity to iron metabolism. Weiss G, Wachter H, Fuchs D. Immunol.Today (1995) 16: 495-500.

 

Detection of bacterial pyrogens on the basis of their effects on gamma interferon-mediated formation of neopterin or nitrite in cultured monocyte cell lines. Werner-Felmayer G, Baier-Bitterlich G, Fuchs D, Hausen A, Murr C, Reibnegger G, Werner ER, Wachter H. Clin.Diagn.Lab Immunol. (1995) 2: 307-313.

 

Serum nitrite plus nitrate in infection with human immunodeficiency virus type-1. Zangerle R, Fuchs D, Reibnegger G, Werner-Felmayer G, Gallati H, Wachter H, Werner ER. Immunobiology (1995) 193: 59-70.

 

Factors influencing serum neopterin and beta 2-microglobulin levels in a healthy diverse population. Diamondstone LS, Tollerud DJ, Fuchs D, Wachter H, Brown LM, Maloney E, Kurman CC, Nelson DL, Blattner WA. J.Clin.Immunol. (1994) 14: 368-374.

 

Cyclosporin for erythropoietin resistance. Fuchs D, Weiss G, Murr C, Wachter H. Lancet (1994) 343: 1231.

 

Neopterin–its clinical use in urinalysis. Fuchs D, Stahl-Hennig C, Gruber A, Murr C, Hunsmann G, Wachter H. Kidney Int.Suppl (1994) 47: S8-11.

 

Human immunodeficiency virus infection of the nervous system. Fuchs D, Dierich MP, Wachter H. Ann.Neurol. (1994) 35: 125-126.

 

Neopterin and HIV infection. Fuchs D, Zangerle R, Murr C, Dierich MP, Wachter H. Acta Microbiol.Immunol.Hung. (1994) 41 Suppl: 21-25.

Inhibitory cytokines in patients with anemia of chronic disorders. Fuchs D, Zangerle R, Denz H, Wachter H. Ann.N.Y.Acad.Sci. (1994) 718: 344-346.

 

HIV myelopathy. Fuchs D, Murr C, Reibnegger G, Wachter H. Neurology (1994) 44: 578-579.

 

Nitric oxide synthase and antimicrobial armature of human macrophages. Fuchs D, Murr C, Reibnegger G, Weiss G, Werner ER, Werner-Felmayer G, Wachter H. J.Infect.Dis. (1994) 169: 224-225.

 

Oxidative stress and apoptosis. Fuchs D, Gruber A, Uberall F, Wachter H. Immunol.Today (1994) 15: 496.

 

Clozapine treatment of bipolar disorder in a young adolescent. Fuchs DC. J.Am.Acad.Child Adolesc.Psychiatry (1994) 33: 1299-1302.

 

Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancer. Fuith LC, Czarnecki M, Wachter H, Fuchs D. Obstet.Gynecol. (1994) 83: 801.

 

Neopterin production and tryptophan degradation in acute Lyme neuroborreliosis versus late Lyme encephalopathy. Gasse T, Murr C, Meyersbach P, Schmutzhard E, Wachter H, Fuchs D. Eur.J.Clin.Chem.Clin.Biochem. (1994) 32: 685-689.

 

Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1 infection. Gisslen M, Larsson M, Norkrans G, Fuchs D, Wachter H, Hagberg L. AIDS Res.Hum.Retroviruses (1994) 10: 947-951.

 

Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study. Gisslen M, Chiodi F, Fuchs D, Norkrans G, Svennerholm B, Wachter H, Hagberg L. Scand.J.Infect.Dis. (1994) 26: 523-533.

 

Increased production of immune activation marker neopterin by colony-stimulating factors in gynecological cancer patients. Marth C, Weiss G, Koza A, Reibnegger G, Daxenbichler G, Zeimet AG, Fuchs D, Wachter H, Dapunt O. Int.J.Cancer (1994) 58: 20-23.

 

Activated cellular immunity in ovarian carcinoma patients. Marth C, Fuchs D. Am.J.Obstet.Gynecol. (1994) 171: 1159-1160.

 

Immune activation and enhanced urinary zinc concentrations in allograft recipients. Melichar B, Aichberger C, Artner-Dworzak E, Weiss G, Margreiter R, Wachter H, Fuchs D. Presse Med. (1994) 23: 702-706.

 

Enhancement of hydrogen peroxide-induced luminol-dependent chemiluminescence by neopterin depends on the presence of iron chelator complexes. Murr C, Fuchs D, Gossler W, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Esterbauer H, Wachter H. FEBS Lett. (1994) 338: 223-226.

 

Prognostic factors for multiple myeloma. Reibnegger G, Fuchs D, Wachter H. Blood (1994) 84: 1350-1351.

 

Soluble tumour necrosis factor receptors as prognostic factors in cancer. Reibnegger G, Diez-Ruiz A, Fuchs D, Wachter H. Lancet (1994) 344: 681-682.

 

Increased prevalence of IgM antibodies to Epstein-Barr virus and parvovirus B19 in blood donations with above-normal neopterin. Schennach H, Mayersbach P, Schonitzer D, Fuchs D, Wachter H, Reibnegger G. Clin.Chem. (1994) 40: 2104-2105.

 

[Activated macrophages in the pathologic mechanism of pregnancy-induced hypertension]. Schrocksnadel H, Fuchs D, Herold M, Wachter H, Dapunt O. Zentralbl.Gynakol. (1994) 116: 274-275.

 

Neopterin derivatives together with cyclic guanosine monophosphate induce c-fos gene expression. Uberall F, Werner-Felmayer G, Schubert C, Grunicke HH, Wachter H, Fuchs D. FEBS Lett. (1994) 352: 11-14.

 

Increased concentrations of neopterin in carotid atherosclerosis. Weiss G, Willeit J, Kiechl S, Fuchs D, Jarosch E, Oberhollenzer F, Reibnegger G, Tilz GP, Gerstenbrand F, Wachter H. Atherosclerosis (1994) 106: 263-271.

 

Stimulation of IRE-BP activity of IRF by tetrahydrobiopterin and cytokine dependent induction of nitric oxide synthase. Weiss G, Goossen B, Doppler W, Fuchs D, Pantopoulos K, Werner-Felmayer G, Grunewald K, Wachter H, Hentze MW. Adv.Exp.Med.Biol. (1994) 356: 133-139.

 

Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation. Zangerle R, Sarcletti M, Gallati H, Reibnegger G, Wachter H, Fuchs D. J.Acquir.Immune.Defic.Syndr. (1994) 7: 1149-1156.

 

Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection. Zangerle R, Gallati H, Sarcletti M, Wachter H, Fuchs D. Immunol.Lett. (1994) 41: 229-234.

 

Activated macrophages and radicals in scleroderma. Zangerle R, Wachter H, Fuchs D. J.Am.Acad.Dermatol. (1994) 30: 1045-1047.

 

Correlation of body mass index with urinary neopterin in individuals infected with human immunodeficiency virus. Zangerle R, Sarcletti M, Gallati H, Reibnegger G, Wachter H, Fuchs D. Int.Arch.Allergy Immunol. (1994) 104: 150-154.

 

Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection. Zangerle R, Fuchs D, Sarcletti M, Gallati H, Reibnegger G, Wachter H, Dierich MP, Most J. Clin.Immunol.Immunopathol. (1994) 72: 328-334.

 

Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation. Zangerle R, Gallati H, Sarcletti M, Weiss G, Denz H, Wachter H, Fuchs D. J.Acquir.Immune.Defic.Syndr. (1994) 7: 79-85.

 

Serum soluble tumour necrosis factor receptor 55 is increased in patients with haematological neoplasias and is associated with immune activation and weight loss. Denz H, Orth B, Weiss G, Gallati H, Herrmann R, Huber P, Wachter H, Fuchs D. Eur.J.Cancer (1993) 29A: 2232-2235.

 

Immune activation and anemia of chronic disorders. Denz H, Orth B, Huber P, Gallati H, Wachter H, Fuchs D. Blood (1993) 81: 1404.

 

Weight loss in patients with hematological neoplasias is associated with immune system stimulation. Denz H, Orth B, Weiss G, Herrmann R, Huber P, Wachter H, Fuchs D. Clin.Investig. (1993) 71: 37-41.

 

Increased interferon-gamma and neopterin concentrations in patients with acute brucellosis. Diez-Ruiz A, al Amrani M, Weiss G, Gutierrez-Gea F, Wachter H, Fuchs D. J.Infect.Dis. (1993) 167: 504-505.

 

Association between haemoglobin and neopterin concentrations in haemodialysis patients treated with erythropoietin. Diez-Ruiz A, Weiss G, Artner-Dworzak E, Dittrich PV, Wachter H, Fuchs D. Eur.J.Haematol. (1993) 51: 175-176.

 

Increased levels of serum intercellular adhesion molecule 1 in HIV infection are related to immune activation. Diez-Ruiz A, Kaiser G, Jager H, Birkmann J, Tilz GP, Wachter H, Fuchs D. Int.Arch.Allergy Immunol. (1993) 102: 56-60.

 

Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Fuchs D, Zangerle R, Artner-Dworzak E, Weiss G, Fritsch P, Tilz GP, Dierich MP, Wachter H. Eur.J.Haematol. (1993) 50: 90-94.

 

Bad teeth and myocardial infarction. Biological mechanisms for link. Fuchs D, Reibnegger G, Wachter H. BMJ (1993) 306: 1196.

 

Interleukin-10 for common variable immunodeficiency. Fuchs D, Weiss G, Murr C, Wachter H. Lancet (1993) 342: 1363.

 

Making the blood supply safer. Fuchs D, Weiss G, Wachter H. Ann.Intern.Med. (1993) 118: 574-575.

 

[The clinical significance of neopterin in human diseases]. Fuchs D, Samsonov MI, Weiss G, Reibnegger G, Nasonov EL, Wachter H. Ter.Arkh. (1993) 65: 80-87.

 

Stimulated cellular immune system in patients with congestive heart failure. Fuchs D, Samsonov M, Tilz GP, Reibnegger G, Belenkov JN, Nassonov EL, Wachter H. Eur.J.Clin.Chem.Clin.Biochem. (1993) 31: 111-114.

 

Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Fuchs D, Weiss G, Wachter H. Int.Arch.Allergy Immunol. (1993) 101: 1-6.

 

Clues to enhancing the identification of human immunodeficiency virus-infected women. Fuith LC, Czarnecki M, Weiss G, Wachter H, Fuchs D. Obstet.Gynecol. (1993) 81: 159-160.

 

[Changes in cell-mediated immunity after gynecologic interventions]. Fuith LC, Kracher P, Czarnecki M, Wachter H, Fuchs D. Gynakol.Geburtshilfliche Rundsch. (1993) 33 Suppl 1: 280.

 

Prognosis of human immunodeficiency virus-infected women after delivery. Fuith LC, Czarnecki M, Weiss G, Wachter H, Fuchs D. Am.J.Obstet.Gynecol. (1993) 169: 752-753.

 

Cerebrospinal fluid neopterin concentrations in central nervous system infection. Hagberg L, Dotevall L, Norkrans G, Larsson M, Wachter H, Fuchs D. J.Infect.Dis. (1993) 168: 1285-1288.

 

Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. Lang SM, Weeger M, Stahl-Hennig C, Coulibaly C, Hunsmann G, Muller J, Muller-Hermelink H, Fuchs D, Wachter H, Daniel MM, . J.Virol. (1993) 67: 902-912.

 

Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation. Markewitz A, Faist E, Lang S, Endres S, Fuchs D, Reichart B. J.Thorac.Cardiovasc.Surg. (1993) 105: 15-24.

 

The prognostic value of nuclear roundness and neopterin in ovarian cancer. Marth C, Weger A, Muller-Holzner E, Zeimet AG, Moncayo-Naveda H, Daxenbichler G, Reibnegger G, Fuchs D, Wachter H, Dapunt O. Eur.J.Cancer (1993) 29A: 1863-1868.

 

Elevated concentrations of circulating intercellular adhesion molecule 1 (ICAM-1) in HIV-1 infection. Most J, Zangerle R, Herold M, Fuchs D, Wachter H, Fritsch P, Dierich MP. J.Acquir.Immune.Defic.Syndr. (1993) 6: 221-226.

 

Serum neopterin in acute rheumatic fever. Samsonov M, Nassonov E, Dhzuzenova B, Belenkov Y, Nassonova V, Wachter H, Fuchs D. Clin.Chem. (1993) 39: 693-695.

 

Captopril and the effect of interferon gamma on monocytes. Samsonov M, Nassonov E, Werner-Felmayer G, Fuchs D, Wachter H. Arch.Intern.Med. (1993) 153: 1138, 1142.

 

Urine neopterin concentrations and activity of psoriasis . Sepp N, Benedikter S, Kofler H, Wachter H, Fuchs D. Br.J.Dermatol. (1993) 129: 498-499.

 

Increased immune activation during and after physical exercise. Tilz GP, Domej W, Diez-Ruiz A, Weiss G, Brezinschek R, Brezinschek HP, Huttl E, Pristautz H, Wachter H, Fuchs D. Immunobiology (1993) 188: 194-202.

 

Comparative effects of heme and metalloporphyrins on interferon-gamma-mediated pathways in monocytic cells (THP-1). Weiss G, Lutton JD, Fuchs D, Werner-Felmayer G, Bock G, Abraham NG, Kappas A, Levere RD, Wachter H. Proc.Soc.Exp.Biol.Med. (1993) 202: 470-475.

 

Neopterin modulates toxicity mediated by reactive oxygen and chloride species. Weiss G, Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Semenitz E, Dierich MP, Wachter H. FEBS Lett. (1993) 321: 89-92.

 

High stored iron levels and the risk of myocardial infarction. Weiss G, Fuchs D, Wachter H. Circulation (1993) 87: 1425-1426.

 

Iron and coronary heart disease. Iron linked to immune activation. Weiss G, Reibnegger G, Murr C, Wachter H, Fuchs D. BMJ (1993) 307: 1067.

 

Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. Weiss G, Goossen B, Doppler W, Fuchs D, Pantopoulos K, Werner-Felmayer G, Wachter H, Hentze MW. EMBO J. (1993) 12: 3651-3657.

 

Interferon-gamma and coronary lesions in HIV infection. Weiss G, Zangerle R, Wachter H, Fuchs D. Lancet (1993) 341: 383.

 

Ca2+/calmodulin-dependent nitric oxide synthase activity in the human cervix carcinoma cell line ME-180. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Mayer B, Reibnegger G, Weiss G, Wachter H. Biochem.J. (1993) 289 ( Pt 2): 357-361.

 

Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Schmidt K, Weiss G, Wachter H. J.Biol.Chem. (1993) 268: 1842-1846.

 

Antiretroviral therapy in sporadic adult amyotrophic lateral sclerosis. Westarp ME, Bartmann P, Rossler J, Geiger E, Westphal KP, Schreiber H, Fuchs D, Westarp MP, Kornhuber HH. Neuroreport (1993) 4: 819-822.

 

Amyotrophic lateral sclerosis an enigmatic disease with B-cellular and anti-retroviral immune responses. Westarp ME, Fuchs D, Bartmann P, Hoff-Jorgensen R, Clausen J, Wachter H, Kornhuber HH. Eur.J.Med. (1993) 2: 327-332.

 

Effect of pteridine derivatives on intracellular calcium concentration in human monocytic cells. Woll E, Weiss G, Fuchs D, Lang F, Wachter H. FEBS Lett. (1993) 318: 249-252.

 

Association between neopterin and beta-2-microglobulin levels and HIV status in Romanian orphanage children. Zaknun D, DiFranco M, Oswald HP, Zaknun J, Mayersbach P, Vuja E, Wachter H, Fuchs D. Wien.Klin.Wochenschr. (1993) 105: 284-288.

 

Neopterin levels during acute rubella in children. Zaknun D, Weiss G, Glatzl J, Wachter H, Fuchs D. Clin.Infect.Dis. (1993) 17: 521-522.

Weight loss in HIV-1 infection is associated with immune activation. Zangerle R, Reibnegger G, Wachter H, Fuchs D. AIDS (1993) 7: 175-181.

 

Association between the activation of macrophages, changes of iron metabolism and the degree of anaemia in patients with malignant disorders. Denz H, Huber P, Landmann R, Orth B, Wachter H, Fuchs D. Eur.J.Haematol. (1992) 48: 244-248.

 

Altered iron metabolism and the anemia of chronic disease: a role of immune activation. Denz H, Fuchs D, Wachter H. Blood (1992) 79: 2797-2798.

Pathogenesis of chronic fatigue syndrome. Fuchs D, Weiss G, Wachter H. J.Clin.Psychiatry (1992) 53: 296.

 

Anemia of chronic disease: a misnomer? Fuchs D, Weiss D, Wachter H. Ann.Intern.Med. (1992) 116: 520.

 

Erythropoietin and decreased erythropoiesis in pregnancy . Fuchs D, Weiss G, Werner-Felmayer G, Wachter H. Blood (1992) 79: 533-534.

 

Immune activation and neuronal injury in AIDS. Fuchs D, Weiss G, Werner-Felmayer G, Reibnegger G, Wachter H. Trends Neurosci. (1992) 15: 253-254.

 

Increased interferon-gamma and reduced hemoglobin in patients with human immunodeficiency virus type 1 infection. Fuchs D, Zangerle R, Artner-Dworzak E, Weiss G, Werner-Felmayer G, Wachter H. J.Acquir.Immune.Defic.Syndr. (1992) 5: 424-425.

 

[Neopterin and blood transfusion]. Fuchs D, Wachter H, Schonitzer D. Dtsch.Med.Wochenschr. (1992) 117: 1578-1579.

 

The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Fuchs D, Weiss G, Reibnegger G, Wachter H. Crit Rev.Clin.Lab Sci. (1992) 29: 307-341.

 

Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b. Fuchs D, Norkrans G, Wejstal R, Reibnegger G, Weiss G, Weiland O, Schvarcz R, Fryden A, Wachter H. Eur.J.Med. (1992) 1: 196-200.

 

Mode of delivery in HIV-1-infected women. Fuith LC, Czarnecki M, Wachter H, Fuchs D. Lancet (1992) 339: 1603.

 

Cerebrospinal fluid neopterin and beta 2-microglobulin levels in neurologically asymptomatic HIV-infected patients before and after initiation of zidovudine treatment. Hagberg L, Norkrans G, Andersson M, Wachter H, Fuchs D. Infection (1992) 20: 313-315.

 

Neopterin screening and acute cytomegalovirus infections in blood donors. Honlinger M, Fuchs D, Reibnegger G, Schonitzer D, Dierich MP, Wachter H. Clin.Investig. (1992) 70: 63.

 

Early changes of neopterin concentrations during treatment of human immunodeficiency virus infection with zidovudine. Hutterer J, Armbruster C, Wallner G, Fuchs D, Vetter N, Wachter H. J.Infect.Dis. (1992) 165: 783-784.

 

Prognostic value of serum beta 2-microglobulin in HIV infection. Kramer A, Goedert JJ, Wachter H, Fuchs D. Lancet (1992) 340: 371.

 

Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific. Kramer A, Biggar RJ, Hampl H, Friedman RM, Fuchs D, Wachter H, Goedert JJ. Am.J.Epidemiol. (1992) 136: 71-80.

 

Critical study of consensus analysis. Reibnegger G, Fuchs D, Judmaier G, Weiss G, Werner-Felmayer G, Wachter H. Lancet (1992) 339: 1394-1397.

 

Serum kynurenine and neopterin concentrations in patients with cardiomyopathy. Rudzite V, Skards JI, Fuchs D, Reibnegger G, Wachter H. Immunol.Lett. (1992) 32: 125-129.

 

Patterns of serological markers for cellular immune activation in patients with dilated cardiomyopathy and chronic myocarditis. Samsonov M, Fuchs D, Reibnegger G, Belenkov JN, Nassonov EL, Wachter H. Clin.Chem. (1992) 38: 678-680.

 

[Cellular immunity in pregnancy-induced hypertensive diseases]. Schrocksnadel H, Herold M, Steckel-Berger G, Fuchs D, Wachter H, Dapunt O. Geburtshilfe Frauenheilkd. (1992) 52: 592-595.

 

[Neopterin (in urine) in patients with pre-eclampsia]. Schrocksnadel H, Fuchs D, Wachter H, Dapunt O. Gynakol.Geburtshilfliche Rundsch. (1992) 32 Suppl 1: 151.

 

Neopterin production in acute schizophrenic patients: an indicator of alterations of cell-mediated immunity. Sperner-Unterweger B, Barnas C, Fuchs D, Kemmler G, Wachter H, Hinterhuber H, Fleischhacker WW. Psychiatry Res. (1992) 42: 121-128.

 

Immunization with tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection. Stahl-Hennig C, Voss G, Nick S, Petry H, Fuchs D, Wachter H, Coulibaly C, Luke W, Hunsmann G. Virology (1992) 186: 588-596.

 

Association between serum-soluble CD8 levels and parameters of immune activation in patients with human immunodeficiency virus infection . Tilz GP, Zangerle R, Weiss G, Fritsch P, Wachter H, Fuchs D. Clin.Investig. (1992) 70: 662-664.

 

Immunization of rhesus monkeys with high- and low-dose Tween-ether-disrupted SIVMAC. Voss G, Stahl-Hennig C, Petry H, Coulibaly C, Nick S, Fuchs D, Wachter H, Luke W, Hunsmann G. AIDS Res.Hum.Retroviruses (1992) 8: 1397-1400.

 

Hyperphenylalaninemia. Weiss G, Fuchs D, Werner-Felmayer G, Wachter H. Neurology (1992) 42: 704-705.

 

Therapy of Plasmodium falciparum parasitemia with desferrioxamine. Weiss G, Fuchs D, Werner-Felmayer G, Wachter H. Blood (1992) 80: 843-844.

 

Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Weiss G, Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Wachter H. Exp.Hematol. (1992) 20: 605-610.

 

Distinct distributions of D-erythro-neopterin in arteries and veins and its recovery by an enterohepatic circulation. Weiss G, Glaser K, Kronberger P, Ambach E, Fuchs D, Bodner E, Wachter H. Biol.Chem.Hoppe Seyler (1992) 373: 289-294.

 

Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment. Wejstal R, Norkrans G, Weiland O, Schvarcz R, Fuchs D, Wachter H, Fryden A, Glaumann H. Clin.Exp.Immunol. (1992) 87: 340-345.

 

Immune activation markers and CD4+ T-cell counts in HIV-infected intravenous drug users. Zangerle R, Wachter H, Fuchs D. J.Acquir.Immune.Defic.Syndr. (1992) 5: 1273-1274.

 

Trends in HIV infection among intravenous drug users in Innsbruck, Austria. Zangerle R, Fuchs D, Rossler H, Reibnegger G, Riemer Y, Weiss SH, Fritsch P, Wachter H. J.Acquir.Immune.Defic.Syndr. (1992) 5: 865-871.

 

Reducing HIV transmission by seronegative blood. Zangerle R, Schonitzer D, Fuchs D, Most J, Dierich MP, Wachter H. Lancet (1992) 339: 130-131.

 

Postmortem neopterin concentrations: comparison of diagnoses with and without cellular immunological background. Ambach E, Tributsch W, Rabl W, Fuchs D, Reibnegger G, Henn R, Wachter H. Int.J.Legal Med. (1991) 104: 259-262.

 

Postmortem evaluation of serum and urine neopterin concentrations. Ambach E, Tributsch W, Fuchs D, Reibnegger G, Henn R, Wachter H. J.Forensic Sci. (1991) 36: 1089-1093.

 

Cigarette smoking: a modifier of human immunodeficiency virus type 1 infection? Burns DN, Kramer A, Yellin F, Fuchs D, Wachter H, DiGioia RA, Sanchez WC, Grossman RJ, Gordin FM, Biggar RJ, . J.Acquir.Immune.Defic.Syndr. (1991) 4: 76-83.

 

Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery. Faist E, Markewitz A, Fuchs D, Lang S, Zarius S, Schildberg FW, Wachter H, Reichart B. Ann.Surg. (1991) 214: 264-273.

 

Negative correlation between blood cell counts and serum neopterin concentration in patients with HIV-1 infection. Fuchs D, Shearer GM, Boswell RN, Lucey DR, Clerici M, Reibnegger G, Werner ER, Zajac RA, Wachter H. AIDS (1991) 5: 209-212.

 

Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Fuchs D, Moller AA, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Immunol.Lett. (1991) 28: 207-211.

 

Immune activation and the anaemia associated with chronic inflammatory disorders. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Eur.J.Haematol. (1991) 46: 65-70.

 

Cytokine-induced increase in liver serotonin. Fuchs D, Weiss G, Werner-Felmayer G, Wachter H. Immunol.Lett. (1991) 28: 259.

 

Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection. Fuchs D, Kramer A, Reibnegger G, Werner ER, Dierich MP, Goedert JJ, Wachter H. Infection (1991) 19 Suppl 2: S98-102.

 

IFN-gamma to treat patients with AIDS. Fuchs D, Reibnegger G, Werner-Felmayer G, Dierich MP, Wachter H. J.Acquir.Immune.Defic.Syndr. (1991) 4: 297-300.

 

Low haemoglobin in haemophilia children is associated with chronic immune activation. Fuchs D, Reibnegger G, Werner ER, Vinazzer H, Wachter H. Acta Haematol. (1991) 85: 62-65.

 

Immune activation and psoriasis. Fuchs D, Sepp N, Susanne B, Fritsch P, Wachter H. Lancet (1991) 338: 759.

 

Prognostic value of CA 125 and neopterin in women with ovarian cancer undergoing second-look laparotomy. Fuith LC, Fuchs D, Reibnegger G, Wachter H. Am.J.Obstet.Gynecol. (1991) 165: 779.

 

Neopterin, a marker of cell-mediated immune activation in human pregnancy. Fuith LC, Fuchs D, Hausen A, Hetzel H, Reibnegger G, Werner ER, Wachter H. Int.J.Fertil. (1991) 36: 372-375.

 

Effect of zidovudine on cerebrospinal fluid in patients with HIV infection and acute neurological disease. Hagberg L, Andersson M, Chiodi F, Fuchs D, Svennerholm B, Wachter H, Norkrans G. Scand.J.Infect.Dis. (1991) 23: 681-685.

 

Evaluation on HIV serology and immune-stimulation on patients in Tanzania. Hengster P, Schmutzhard E, Fuchs D, Hofbauer J, Wachter H, Dierich MP. Int.J.STD AIDS (1991) 2: 180-184.

 

Correlation of the percentage of activated, CD3 + DR + lymphocytes to serum neopterin level in HIV-seropositive haemophiliacs. Paloczi K, Ujhelyi E, Fuchs D, Mihalik R, Banhegyi D, Berkessy S, Salavecz V, Wachter H, Hollan SR, Fust G. Klin.Wochenschr. (1991) 69: 143-145.

 

Neopterin as a marker for activated cell-mediated immunity: application in malignant disease. Reibnegger G, Fuchs D, Fuith LC, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Cancer Detect.Prev. (1991) 15: 483-490.

 

Individual probability for onset of full-blown disease in patients infected with human immunodeficiency virus type 1. Reibnegger G, Spira TJ, Fuchs D, Werner-Felmayer G, Dierich MP, Wachter H. Clin.Chem. (1991) 37: 351-355.

 

Posttransplant neopterin excretion in renal allograft recipients–a reliable diagnostic aid for acute rejection and a predictive marker of long-term graft survival. Reibnegger G, Aichberger C, Fuchs D, Hausen A, Spielberger M, Werner ER, Margreiter R, Wachtehr H. Transplantation (1991) 52: 58-63.

 

Neopterin and psoriasis. Sepp N, Fuchs D, Wachter H. Lancet (1991) 338: 1522.

 

Change in HIV-antibody seroprevalence rates in i.v. drug dependent prisoners. Sperner-Unterweger B, Fuchs D, Fleischhacker WW, Hausen A, Miller C, Most J,

Reibnegger G, Werner ER, Dierich M, Wachter H, . Br.J.Addict. (1991) 86: 225-232.

 

On multiple forms of NO synthase and their occurrence in human cells. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Res.Immunol. (1991) 142: 555-561.

 

Induction of indoleamine 2,3-dioxygenase in human cells in vitro. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Adv.Exp.Med.Biol. (1991) 294: 505-509.

 

Impact of tumour necrosis factor-alpha and interferon-gamma on tetrahydrobiopterin synthesis in murine fibroblasts and macrophages. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Yim JJ, Wachter H. Biochem.J. (1991) 280 ( Pt 3): 709-714.

 

6-Pyruvoyl tetrahydropterin synthase assay in extracts of cultured human cells using high-performance liquid chromatography with fluorescence detection of biopterin. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wels G, Yim JJ, Pfleiderer W, Wachter H. J.Chromatogr. (1991) 570: 43-50.

 

Relationships between pteridine synthesis and tryptophan degradation. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wachter H. Adv.Exp.Med.Biol. (1991) 294: 177-184.

 

Biochemistry and function of pteridine synthesis in human and murine macrophages. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger R, Yim JJ, Wachter H. Pathobiology (1991) 59: 276-279.

 

Nocturnal sleep EEG in patients with HIV infection. Wiegand M, Moller AA, Schreiber W, Krieg JC, Fuchs D, Wachter H, Holsboer F. Eur.Arch.Psychiatry Clin.Neurosci. (1991) 240: 153-158.

 

[Effects of health and medical undertreatment on the clinical status and social behavior of infants and small children in a Romanian orphanage]. Zaknun D, Oswald HP, Zaknun J, Mayersbach P, Sperl W, Schmitzberger R, Fuchs D, Sailer M. Padiatr.Padol. (1991) 26: 65-67.

 

Markers for disease progression in intravenous drug users infected with HIV-1. Zangerle R, Fuchs D, Reibnegger G, Fritsch P, Wachter H. AIDS (1991) 5: 985-991.

 

Value of urinary neopterin in the differential diagnosis of bacterial and viral infections. Denz H, Fuchs D, Hausen A, Huber H, Nachbaur D, Reibnegger G, Thaler J, Werner ER, Wachter H. Klin.Wochenschr. (1990) 68: 218-222.

 

Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders. Denz H, Fuchs D, Huber H, Nachbaur D, Reibnegger G, Thaler J, Werner ER, Wachter H. Eur.J.Haematol. (1990) 44: 186-189.

 

Interaction of complement with HIV-1 and Candida albicans: molecular mechanisms and biological implications. Dierich MP, Ebenbichler CF, Hallfeldt PH, Prodinger WM, Fuchs D, Wachter H. Mol.Immunol. (1990) 27: 1349-1353.

 

Cerebrospinal fluid and serum neopterin levels in patients with Lyme neuroborreliosis. Dotevall L, Fuchs D, Reibnegger G, Wachter H, Hagberg L. Infection (1990) 18: 210-214.

 

Immune-mediated mechanisms in multiple sclerosis. Fuchs D, Reibnegger G, Werner ER, Wachter H. J.Neurol. (1990) 237: 125.

 

Urinary excretion of porphyrins is increased in patients with HIV-1 infection. Fuchs D, Artner-Dworzak E, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. AIDS (1990) 4: 341-344.

 

Interactions between immune activation cascades and biosynthesis of neurotransmitters. Fuchs D, Werner-Felmayer G, Dierich MP, Wachter H. Immunol.Today (1990) 11: 348.

 

Immune activation and decreased tryptophan in patients with HIV-1 infection. Fuchs D, Forsman A, Hagberg L, Larsson M, Norkrans G, Reibnegger G, Werner ER, Wachter H. J.Interferon Res. (1990) 10: 599-603.

 

Increased 7,8-dihydroneopterin and reduced methyl-group metabolism in HIV-1 infection. Fuchs D, Reibnegger G, Werner ER, Wachter H. Lancet (1990) 335: 1167.

 

Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. Fuchs D, Moller AA, Reibnegger G, Stockle E, Werner ER, Wachter H. J.Acquir.Immune.Defic.Syndr. (1990) 3: 873-876.

 

Immune activation markers to predict AIDS and survival in HIV-1 seropositives. Fuchs D, Jager H, Popescu M, Reibnegger G, Werner ER, Dierich MP, Kaboth W, Tilz GP, Wachter H. Immunol.Lett. (1990) 26: 75-79.

 

Comparison of serum and urine neopterin concentrations in patients with HIV-1 infection. Fuchs D, Jaeger H, Popescu M, Reibnegger G, Werner ER, Kaboth W, Wachter H. Clin.Chim.Acta (1990) 187: 125-130.

 

Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production. Fuchs D, Shearer GM, Boswell RN, Clerici M, Reibnegger G, Werner ER, Zajac RA, Wachter H. Clin.Exp.Immunol. (1990) 80: 44-48.

 

[Comments on the contribution „Changes in T-cell subpopulations in normal pregnancy and in patients with spontaneous abortions“ by C. J. Thaler, L. J. Behnken, H. D. Taubert]. Fuith LC, Fuchs D, Reibnegger G, Dapunt O, Wachter H. Geburtshilfe Frauenheilkd. (1990) 50: 825.

 

Interferon gamma and depressed cellular immune response. Fuith LC, Fuchs D, Wachter H. Am.J.Obstet.Gynecol. (1990) 162: 1338.

 

Urinary neopterin excretion in patients with uterine sarcomas. Fuith LC, Fuchs D, Hausen A, Hetzel H, Reibnegger G, Werner ER, Wachter H. Cancer (1990) 65: 1228-1231.

 

Decreased haemoglobin and chronic immune activation in patients with gynaecologic malignancies. Fuith LC, Fuchs D, Hausen A, Heim K, Schrocksnadel H, Reibnegger G, Werner ER, Wachter H. Eur.J.Haematol. (1990) 45: 280-282.

 

Increased CSF neopterin levels in subarachnoid hemorrhage. Mathiesen T, Fuchs D, Wachter H, von Holst H. J.Neurosurg. (1990) 73: 69-71.

 

Increased neopterin concentration in saliva of patients with HIV-1 infection. Reibnegger G, Fuchs D, Zangerle R, Wachter H. Clin.Chem. (1990) 36: 1379-1380.

 

Urinary neopterin concentrations and T-cell subset data in HIV-1 infection. Reibnegger G, Fuchs D, Goedert JJ, Hausen A, Kramer A, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Klin.Wochenschr. (1990) 68: 43-48.

 

Unconjugated pteridines and the activation of macrophages by interferon gamma. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Cancer Chemother.Pharmacol. (1990) 25: 308-309.

 

Age dependency of the progression of HIV disease in haemophiliacs; predictive value of T cell subset and neopterin measurements. Ujhelyi E, Fuchs D, Krall G, Zimonyi I, Berkessy S, Bujdoso S, Paloczi K, Mihalik R, Fust G, Wachter H, . Immunol.Lett. (1990) 26: 67-73.

 

Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Cancer Res. (1990) 50: 2863-2867.

 

Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. J.Exp.Med. (1990) 172: 1599-1607.

 

Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells. GTP-cyclohydrolase I is stimulated by interferon-gamma, and 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase are constitutively present. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Yim JJ, Pfleiderer W, Wachter H. J.Biol.Chem. (1990) 265: 3189-3192.

 

Production and characterization of a monoclonal antibody against neopterin. Weyrer W, Most J, Solder B, Fuchs D, Wachter H, Dierich MP. Hybridoma (1990) 9: 71-79.

HIV infection and tuberculosis. Zangerle R, Fritsch P, Fuchs D, Wachter H. BMJ (1990) 300: 814.

 

AIDS: T cell activation and viral progression. Dierich MP, Larcher C, Soldner B, Bitterlich G, Fuchs D, Wachter H. Curr.Probl.Dermatol. (1989) 18: 229-235.

 

Urinary neopterin concentrations in rhesus monkeys after infection with simian immunodeficiency virus (SIVmac 251). Fendrich C, Luke W, Stahl-Hennig C, Herchenroder O, Fuchs D, Wachter H, Hunsmann G. AIDS (1989) 3: 305-307.

 

Cell-mediated immunoreactivity in AIDS. Fuchs D, Werner ER, Dierich MP, Wachter H. Immunol.Today (1989) 10: 150.

 

Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1. Fuchs D, Chiodi F, Albert J, Asjo B, Hagberg L, Hausen A, Norkrans G, Reibnegger G, Werner ER, Wachter H. AIDS (1989) 3: 285-288.

 

Interactions between haemopoietic growth factors. Fuchs D, Artner-Dworzak E, Fuith LC, Reibnegger G, Wachter H. Lancet (1989) 1: 1266.

 

Circulating gamma-interferon in patients with aplastic anemia. Fuchs D, Denz HA, Nachbauer D, Reibnegger G, Wachter H. Blood (1989) 73: 858-859.

 

Cytokines and acquired immunodeficiency syndrome. Fuchs D, Reibnegger G, Dierich MP, Wachter H. Am.J.Med. (1989) 86: 509.

 

Interferon-gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. J.Acquir.Immune.Defic.Syndr. (1989) 2: 158-162.

 

Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation. Fuchs D, Malkovsky M, Reibnegger G, Werner ER, Forni G, Wachter H. Immunol.Lett. (1989) 23: 103-108.

 

Beta 2-microglobulin and immune activation.   Fuchs D, Hausen A, Reibnegger G, Werner ER, Felmayer G, Wachter H. Clin.Chem. (1989) 35: 2158-2159.

 

Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection. Fuchs D, Spira TJ, Hausen A, Reibnegger G, Werner ER,

Felmayer G, Wachter H. Clin.Chem. (1989) 35: 1746-1749.

 

AIDS incidence rates in Austria. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Wien.Klin.Wochenschr. (1989) 101: 388-390.

 

Association between serum neopterin concentrations and in vitro replicative capacity of HIV-1 isolates. Fuchs D, Albert J, Asjo B, Fenyo EM, Reibnegger G, Wachter H. J.Infect.Dis. (1989) 160: 724-725.

 

Urinary neopterin concentrations vs total neopterins for clinical utility. Fuchs D, Milstien S, Kramer A, Reibnegger G, Werner ER, Goedert JJ, Kaufman S, Wachter H. Clin.Chem. (1989) 35: 2305-2307.

 

Cellular immune activation and erythropoiesis in gynaecological cancer. Fuith LC, Fuchs D, Reibnegger G, Wachter H. Lancet (1989) 1: 908.

 

Effects of interferon-alpha on macrophage activation in patients with ovarian carcinoma and cervical dysplasia. Fuith LC, Fuchs D, Hausen A, Hetzel H, Reibnegger G, Werner ER, Wachter H. J.Clin.Lab Immunol. (1989) 29: 65-69.

 

[Serum neopterin determination for the additional safeguarding of blood transfusions. Our experiences with 76,587 blood donors]. Honlinger M, Fuchs D, Hausen A, Reibnegger G, Schonitzer D, Werner ER, Reissigl H, Dierich MP, Wachter H. Dtsch.Med.Wochenschr. (1989) 114: 172-176.

 

Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infection. Kramer A, Wiktor SZ, Fuchs D, Milstien S, Gail MH, Yellin FJ, Biggar RJ, Wachter H, Kaufman S, Blattner WA, . J.Acquir.Immune.Defic.Syndr. (1989) 2: 291-296.

 

Stability analysis of simple models for immune cells interacting with normal pathogens and immune system retroviruses. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Dierich MP, Wachter H. Proc.Natl.Acad.Sci.U.S.A (1989) 86: 2026-2030.

 

Concentrations of neopterin in serum of recipients of renal allografts. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Clin.Chem. (1989) 35: 2157.

 

Generalized likelihood ratio concept and logistic regression analysis for multiple diagnostic categories. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Clin.Chem. (1989) 35: 990-994.

 

Monitoring of serum neopterin levels for diagnosis of acute rejection of renal allografts. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Nephron (1989) 52: 100.

 

Neopterin and viral infections: diagnostic potential in virally induced liver disease. Reibnegger G, Fuchs D, Hausen A, Werner ER, Werner-Felmayer G, Wachter H. Biomed.Pharmacother. (1989) 43: 287-293.

 

Retroviral infections (HIV-1, HIV-2, and HTLV-I) in rural northwestern Tanzania. Clinical findings, epidemiology, and association with infections common in Africa. Schmutzhard E, Fuchs D, Hengster P, Hausen A, Hofbauer J, Pohl P, Rainer J, Reibnegger G, Tibyampansha D, Werner ER, . Am.J.Epidemiol. (1989) 130: 309-318.

 

Is schizophrenia linked to alteration in cellular immunity? Sperner-Unterweger B, Barnas C, Fleischhacker WW, Fuchs D, Meise U, Reibnegger G, Wachter H. Schizophr.Res. (1989) 2: 417-421.

 

Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER. Adv.Clin.Chem. (1989) 27: 81-141.

 

Characteristics of interferon induced tryptophan metabolism in human cells in vitro. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Biochim.Biophys.Acta (1989) 1012: 140-147.

 

Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Biol.Chem.Hoppe Seyler (1989) 370: 1063-1069.

 

Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wachter H. Biochem.J. (1989) 262: 861-866.

 

Selective induction of mononuclear phagocytes to produce neopterin by interferons. Bitterlich G, Szabo G, Werner ER, Larcher C, Fuchs D, Hausen A, Reibnegger G, Schulz TF, Troppmair J, Wachter H, . Immunobiology (1988) 176: 228-235.

 

[Etiology–characteristics of HIV infection]. Dierich MP, Larcher C, Solder B, Schulz TF, Fuchs D, Wachter H. Wien.Med.Wochenschr. (1988) 138: 482-486.

 

Anti-HIV-1 antibodies, anti-HTLV-I antibodies and neopterin levels in parenteral drug addicts in the Austrian Tyrol. Fuchs D, Unterweger B, Hausen A, Reibnegger G, Werner ER, Hengster P, Hinterhuber H, Dierich MP, Wachter H, Blattner WA, . J.Acquir.Immune.Defic.Syndr. (1988) 1: 65-66.

 

Predicting AIDS. Fuchs D, Dierich MP, Wachter H. BMJ (1988) 297: 1543.

 

Neopterin levels in long-term hemodialysis.   Fuchs D, Hausen A, Reibnegger G, Werner ER, von Dittrich P, Wachter H. Clin.Nephrol. (1988) 30: 220-224.

 

[Aluminum and dihydropteridine reductase in Alzheimer’s disease]. Fuchs D, Werner ER, Wachter H. Dtsch.Med.Wochenschr. (1988) 113: 877.

 

Neopterin as a marker in HIV infection. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Clin.Chem. (1988) 34: 466-467.

 

Inflammatory joint disease and HIV infection. Fuchs D, Wachter H. BMJ (1988) 297: 422-423.

 

Cytomegalovirus infection. Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H. Wien.Klin.Wochenschr. (1988) 100: 303.

 

Immunological status and HIV antibodies in patients with haemophilia–a longitudinal study. Fuchs D, Hausen A, Reibnegger G, Werner ER, Vinazzer H, Dierich MP, Wachter H. Wien.Klin.Wochenschr. (1988) 100: 505-509.

 

Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Immunol.Today (1988) 9: 150-155.

 

Neopterin in clinical medicine. Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H. Lancet (1988) 1: 702.

 

Cellular immune activation in the brain and human immunodeficiency virus infection. Fuchs D, Werner ER, Dierich MP, Wachter H. Ann.Neurol. (1988) 24: 289.

 

Urinary neopterin in infants with primary immunodeficiency. Fuchs D, Ebell W, Friedrich W, Hausen A, Reibnegger G, Werner ER, Wachter H. Immunobiology (1988) 177: 1-6.

 

Antigen detection in primary HIV infection.   Fuchs D, Werner ER, Hausen A, Dierich MP, Reibnegger G, Wachter H. Br.Med.J.(Clin.Res.Ed) (1988) 296: 714-715.

 

Neopterin estimation compared with the ratio of T-cell subpopulations in persons infected with human immunodeficiency virus-1. Fuchs D, Banekovich M, Hausen A, Hutterer J, Reibnegger G, Werner ER, Gschnait FD, Dierich MP, Wachter H. Clin.Chem. (1988) 34: 2415-2417.

 

Is T-cell activation an unfavourable sign in i.v.-drug addicts infected with HIV? Fuchs DN, Hausen A, Hengster P, Reibnegger GJ, Unterweger B, Werner ER, Hinterhuber H, Dierich MP, Wachter H. Cancer Detect.Prev. (1988) 12: 277-282.

 

Preactivated T cells in cancer patients with poor prognosis. Fuchs DN, Fuith LC, Hausen A, Hetzel H, Reibnegger GJ, Werner ER, Wachter H. Cancer Detect.Prev. (1988) 12: 97-103.

 

Antigen test v neopterin test. Hengster P, Larcher C, Solder B, Dierich MP, Fuchs D, Wachter H, Schonitzer D. Blood (1988) 72: 1096-1097.

 

Urinary neopterin excretion in pulmonary sarcoidosis: correlation to clinical course of the disease. Prior C, Frank A, Fuchs D, Hausen A, Judmaier G, Reibnegger G, Werner ER, Wachter H. Clin.Chim.Acta (1988) 177: 211-220.

 

Urinary neopterin levels in acute viral hepatitis. Reibnegger G, Auhuber I, Fuchs D, Hausen A, Judmaier G, Prior C, Werner ER, Wachter H. Hepatology (1988) 8: 771-774.

 

Pterins as biochemical tests for diagnosis and management of patients with malignant lymphoma and leukemia. Reibnegger G, Fuchs D, Hausen A, Werner ER, Wachter H. Clin.Chim.Acta (1988) 173: 233-234.

 

[The significance of neopterin determination for transfusion medicine]. Reissigl H, Schonitzer D, Honlinger M, Reibnegger G, Fuchs D, Dierich M, Wachter H. Beitr.Infusionsther. (1988) 21: 211-219.

 

[Neopterin in human immunodeficiency virus (HIV) infection]. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP. Dtsch.Med.Wochenschr. (1988) 113: 1890-1897.

 

Influence of interferon-gamma and extracellular tryptophan on indoleamine 2,3-dioxygenase activity in T24 cells as determined by a non-radiometric assay. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wachter H. Biochem.J. (1988) 256: 537-541.

 

Tryptophan degradation in patients infected by human immunodeficiency virus. Werner ER, Fuchs D, Hausen A, Jaeger H, Reibnegger G, Werner-Felmayer G, Dierich MP, Wachter H. Biol.Chem.Hoppe Seyler (1988) 369: 337-340.

 

Effect of interferon gamma on tryptophan and pteridine metabolism of human cells. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Wachter H. J.Natl.Cancer Inst. (1988) 80: 974-975.

 

Mechanism of defective NK cell activity in patients with AIDS and AIDS-related complex. Fuchs D, Wachter H. J.Immunol. (1987) 138: 1653.

 

Psoriasis, gamma-interferon, and the acquired immunodeficiency syndrome. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Ann.Intern.Med. (1987) 106: 165.

 

HIV vaccination and blood transfusion. Fuchs D, Hausen A, Reibnegger G, Schoenitzer D, Werner ER, Dierich MP, Wachter H. Nature (1987) 330: 702-703.

 

In vivo activation of CD4+ cells in AIDS. Fuchs D, Hausen A, Hengster P, Reibnegger G, Schulz T, Werner ER, Dierich MP, Wachter H. Science (1987) 235: 356.

 

Activated T cells in addition to LAV/HTLV-III infection: a necessary precondition for development of AIDS. Fuchs D, Hausen A, Hoefler E, Schonitzer D, Werner ER,

Dierich MP, Hengster P, Reibnegger G, Schulz T, Wachter H. Cancer Detect.Prev.Suppl (1987) 1: 583-587.

 

Neopterin levels correlating with the Walter Reed staging classification in human immunodeficiency virus (HIV) infection. Fuchs D, Reibnegger G, Wachter H, Jaeger H, Popescu M, Kaboth W. Ann.Intern.Med. (1987) 107: 784-785.

 

HIV seroconversion in health care workers. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. JAMA (1987) 258: 2525-2526.

 

Immune status of drug abusers. Fuchs D, Hausen A, Reibnegger G, Schonitzer D, Unterweger B, Blecha HG, Hengster P, Rossler H, Schulz T, Werner ER, . Cancer

Detect.Prev.Suppl (1987) 1: 535-541.

 

Neopterin excretion does not correlate with erythrocyte sedimentation rate. Hausen A, Fuchs D, Reibnegger G, Werner ER, Wachter H. Klin.Wochenschr. (1987) 65: 1173.

 

Immunosuppressants in treatment of patients with AIDS. Hausen A, Fuchs D, Reibnegger G, Werner ER, Dierich MP, Wachter H. Lancet (1987) 2: 214-215.

 

Neopterin as discriminating and prognostic parameter in healthy homosexuals, ARC and AIDS patients. Hutterer J, Fuchs D, Eder G, Hausen A, Knapp W, Koller U, Reibnegger G, Werner ER, Wachter H, Stingl G, . Wien.Klin.Wochenschr. (1987) 99: 531-535.

 

Urinary neopterin: an early marker of HIV infection. Kofler H, Fuchs D, Hintner H, Wachter H, Fritsch P. Eur.J.Clin.Microbiol. (1987) 6: 698-699.

 

Allogeneic activation is increased during pregnancy. A risk factor in HIV infection? Mayr P, Fuchs D, Fuith L, Hausen A, Reibnegger G, Werner ER, Wachter H. Br.J.Obstet.Gynaecol. (1987) 94: 1000-1001.

 

Potential of urinary neopterin excretion in differentiating chronic non-A, non-B hepatitis from fatty liver. Prior C, Fuchs D, Hausen A, Judmaier G, Reibnegger G, Werner ER, Vogel W, Wachter H. Lancet (1987) 2: 1235-1237.

 

Clinical significance of neopterin for prognosis and follow-up in ovarian cancer. Reibnegger G, Hetzel H, Fuchs D, Fuith LC, Hausen A, Werner ER, Wachter H. Cancer Res. (1987) 47: 4977-4981.

 

The dependence of cell-mediated immune activation in malaria on age and endemicity. Reibnegger G, Fuchs D, Hausen A, Schmutzhard E, Werner ER, Wachter H. Trans.R.Soc.Trop.Med.Hyg. (1987) 81: 729-733.

 

Theoretical implications of cellular immune reactions against helper lymphocytes infected by an immune system retrovirus. Reibnegger G, Fuchs D, Hausen A, Werner ER, Dierich MP, Wachter H. Proc.Natl.Acad.Sci.U.S.A (1987) 84: 7270-7274.

 

Role of activated T lymphocytes in mycosis fungoides. Wehrmann W, Bauer R, Fuchs D, Hausen A, Reibnegger G, Werner ER, Wachter H. Eur.J.Clin.Microbiol. (1987) 6: 210-211.

 

Interferon-gamma-induced degradation of tryptophan by human cells in vitro. Werner ER, Hirsch-Kauffmann M, Fuchs D, Hausen A, Reibnegger G, Schweiger M, Wachter H. Biol.Chem.Hoppe Seyler (1987) 368: 1407-1412.

 

Determination of neopterin in serum and urine. Werner ER, Bichler A, Daxenbichler G, Fuchs D, Fuith LC, Hausen A, Hetzel H, Reibnegger G, Wachter H. Clin.Chem. (1987) 33: 62-66.

 

Human macrophages degrade tryptophan upon induction by interferon-gamma. Werner ER, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G, Dierich MP, Wachter H. Life Sci. (1987) 41: 273-280.

 

Simultaneous determination of neopterin and creatinine in serum with solid-phase extraction and on-line elution liquid chromatography. Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Clin.Chem. (1987) 33: 2028-2033.

 

AIDS in haemophiliacs, parenteral drug abusers, and homosexuals. Fuchs D, Wachter H, Wille R. Lancet (1986) 1: 324.

Immunosuppressants in patients with AIDS. Hausen A, Dierich MP, Fuchs D, Hengster P, Reibnegger G, Schulz T, Werner ER, Wachter H. Nature (1986) 320: 114.

 

HIV infection in renal allograft recipients. Margreiter R, Fuchs D, Hausen A, Hengster P, Schonitzer D, Spielberger M, Dierich MP, Wachter H. Lancet (1986) 2: 398.

 

Urinary neopterin, a marker of clinical activity in patients with Crohn’s disease. Prior C, Bollbach R, Fuchs D, Hausen A, Judmaier G, Niederwieser D, Reibnegger G,

Rotthauwe HW, Werner ER, Wachter H. Clin.Chim.Acta (1986) 155: 11-21.

 

A simple index relating clinical activity in Crohn’s disease with T cell activation: hematocrit, frequency of liquid stools and urinary neopterin as parameters. Reibnegger G, Bollbach R, Fuchs D, Hausen A, Judmaier G, Prior C, Rotthauwe HW, Werner ER, Wachter H. Immunobiology (1986) 173: 1-11.

 

Urinary neopterin reflects clinical activity in patients with rheumatoid arthritis. Reibnegger G, Egg D, Fuchs D, Gunther R, Hausen A, Werner ER, Wachter H. Arthritis Rheum. (1986) 29: 1063-1070.

 

Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Reibnegger GJ, Bichler AH, Dapunt O, Fuchs DN, Fuith LC, Hausen A, Hetzel HM, Lutz H, Werner ER, Wachter H. Cancer Res. (1986) 46: 950-955.

 

Is neopterin–a marker of cell mediated immune response–helpful in classifying leprosy? Schmutzhard E, Fuchs D, Hausen A, Reibnegger G, Wachter H. East Afr.Med.J. (1986) 63: 577-580.

 

[Activation of the macrophage/lymphocyte system in AIDS, ARC and AIDS risk groups]. Wachter H, Blecha HG, Fuchs D, Hausen A, Hengster P, Hinterhuber H, Reibnegger G, Reissigl H, Rossler H, Schonitzer D, . Wien.Klin.Wochenschr. (1986) 98: 449-454.

 

Are conditions linked with T-cell stimulation necessary for progressive HTLV-III infection? Wachter H, Fuchs D, Hausen A, Hengster P, Reibnegger G, Reissigl H, Schoenitzer D, Schulz T, Werner ER, Dierich MP. Lancet (1986) 1: 97.

 

Who will get AIDS? Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP. Lancet (1986) 2: 1216-1217.

 

Significance of urinary neopterin in patients with malignant tumors of the genitourinary tract. Aulitzky W, Frick J, Fuchs D, Hausen A, Reibnegger G, Wachter H. Cancer (1985) 55: 1052-1055.

 

The value of urinary neopterin as an immunological parameter in patients with malignant tumors of the genitourinary tract. Frick J, Aulitzky W, Fuchs D, Hausen A, Joos H, Reibnegger G, Wachter H. Urol.Int. (1985) 40: 155-159.

 

Are homosexuals less at risk of AIDS than intravenous drug abusers and haemophiliacs? Fuchs D, Dierich MP, Hausen A, Hengster P, Reibnegger G, Schulz T, Werner ER, Wachter H. Lancet (1985) 2: 1130.

 

High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian Tyrol. Fuchs D, Blecha HG, Deinhardt F, Dierich MP, Goebel FD, Hengster P, Hinterhuber H, Schoenitzer D, Traill K, Wachter H. Lancet (1985) 1: 1506.

 

Neopterin, a biochemical indicator of cellular immune reactions, in the detection and control of patients with neoplastic diseases. Hausen A, Bichler A, Fuchs D, Hetzel H, Reibnegger G, Wachter H. Cancer Detect.Prev. (1985) 8: 121-128.

 

Neopterin levels in long-term renal allograft recipients . Konig P, Margreiter R, Huber C, Fuchs D, Hausen A, Reibnegger G, Wachter H. Immunobiology (1985) 169: 208-212.

 

Neopterin release in human mixed lymphocyte culture: requirement of HLA-DR disparity. Niederwieser D, Albert E, Fuchs D, Hausen A, Margreiter R, Reibnegger G, Schonitzer D, Troppmair J, Wachter H, Huber C. Immunol.Lett. (1985) 11: 95-99.

 

Neopterin as a new biochemical marker in the clinical assessment of ulcerative colitis. Niederwieser D, Fuchs D, Hausen A, Judmaier G, Reibnegger G, Wachter H, Huber C. Immunobiology (1985) 170: 320-326.

 

Identification of 3-hydroxyanthranilic acid in mixed lymphocyte cultures. Werner ER, Lutz H, Fuchs D, Hausen A, Huber C, Niederwieser D, Pfleiderer W, Reibnegger G, Troppmair J, Wachter H. Biol.Chem.Hoppe Seyler (1985) 366: 99-102.

 

[1st case of AIDS in Salzburg. Important diagnostic hint by determination of neopterin]. Wessely K, Fuchs D, Hausen A, Pilz P, Reibnegger G, Wachter H. Wien.Klin.Wochenschr. (1985) 97: 88-90.

 

Urinary neopterin in the diagnosis and follow-up of neoplasia: a biochemical parameter to detect cell-mediated immune response. Fuchs D, Hausen A, Huber C, Reibnegger G, Wachter H. Tumour.Biol. (1984) 5: 199-209.

 

Neopterin as an index of immune response in patients with tuberculosis. Fuchs D, Hausen A, Kofler M, Kosanowski H, Reibnegger G, Wachter H. Lung (1984) 162: 337-346.

 

Urinary neopterin in the diagnosis of acquired immune deficiency syndrome. Fuchs D, Hausen A, Reibnegger G, Reissigl H, Schonitzer D, Spira T, Wachter H. Eur.J.Clin.Microbiol. (1984) 3: 70-71.

 

Urinary pteridines on patients suffering from cancer. A comment on the method and results of Rao and associates and of Trehan and associates. Hausen A, Fuchs D, Reibnegger G, Wachter H. Cancer (1984) 53: 1634-1636.

 

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H. J.Exp.Med. (1984) 160: 310-316.

 

[Neopterin, a new biochemical marker for clinical assessment of cell-mediated immune response]. Huber C, Fuchs D, Niederwieser D, Hausen A, Reibnegger G, Nilsson K, Wachter H. Klin.Wochenschr. (1984) 62: 103-113.

 

Measurement of urinary 7,8-dihydro-6-hydroxylumazine in healthy and in Ehrlich ascites tumour-bearing mice. Lutz H, Fuchs D, Fuith L, Hausen A, Reibnegger G, Wachter H. Hoppe Seylers.Z.Physiol Chem. (1984) 365: 895-900.

 

Neopterin as a new biochemical marker in the clinical monitoring of bone marrow transplant recipients. Niederwieser D, Huber C, Gratwohl A, Bannert P, Fuchs D, Hausen A, Reibnegger G, Speck B, Wachter H. Transplantation (1984) 38: 497-500.

 

Urinary neopterin is elevated in patients with malaria. Reibnegger G, Boonpucknavig V, Fuchs D, Hausen A, Schmutzhard E, Wachter H. Trans.R.Soc.Trop.Med.Hyg. (1984) 78: 545-546.

 

Measurement of urinary neopterin in normal pregnant and non-pregnant women and in women with benign and malignant genital tract neoplasms. Bichler A, Fuchs D, Hausen A, Hetzel H, Reibnegger G, Wachter H. Arch.Gynecol. (1983) 233: 121-130.

 

Urinary neopterin excretion in coeliac disease. Fuchs D, Granditsch G, Hausen A, Reibnegger G, Wachter H. Lancet (1983) 2: 463-464.

 

Significance of urinary neopterine in gynecological oncology: follow-up of patients with ovarian cancer. Hetzel H, Bichler A, Fuchs D, Hausen A, Reibnegger G, Wachter

H. Cancer Detect.Prev. (1983) 6: 263-266.

 

Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants. Huber C, Fuchs D, Hausen A, Margreiter R, Reibnegger G, Spielberger M, Wachter H. J.Immunol. (1983) 130: 1047-1050.

 

Neopterin as a new biochemical marker for diagnosis of allograft rejection. Experience based upon evaluation of 100 consecutive cases. Margreiter R, Fuchs D, Hausen A, Huber C, Reibnegger G, Spielberger M, Wachter H. Transplantation (1983) 36: 650-653.

 

Elevated urinary neopterin levels in patients with the acquired immunodeficiency syndrome (AIDS). A preliminary report. Wachter H, Fuchs D, Hausen A, Huber C, Knosp O, Reibnegger G, Spira TJ. Hoppe Seylers.Z.Physiol Chem. (1983) 364: 1345-1346.

 

Urinary neopterine excretion in patient with genital cancer. Bichler A, Fuchs D, Hausen A, Hetzel H, Konig K, Wachter H. Clin.Biochem. (1982) 15: 38-40.

 

[Pteridine secretion as a marker for the proliferation of alloantigen-induced lymphocytes (author’s transl)]. Fuchs D, Hausen A, Huber C, Margreiter R, Reibnegger G, Spielberger M, Wachter H. Hoppe Seylers.Z.Physiol Chem. (1982) 363: 661-664.

 

Determination of neopterine in human urine by reversed-phase high-performance liquid chromatography. Hausen A, Fuchs D, Konig K, Wachter H. J.Chromatogr. (1982) 227: 61-70.

 

Urinary neopterine in the assessment of lymphoid and myeloid neoplasia, and neopterine levels in haemolytic anaemia and benign monoclonal gammopathy. Hausen A, Fuchs D, Grunewald K, Huber H, Konig K, Wachter H. Clin.Biochem. (1982) 15: 34-37.

 

The interactions of cations with alkyl substituted acetamide in HF SCF model calculations. Fuchs D, Rode BM. Chem Phys Lett (1981) 82: 517-519.

 

Substituenteneinfluß auf die Bindung von Metallkationen an Amiden. Fuchs DN, Rode BM. Monatsh Chemie (1981) 112: 25-31.

 

Urinary neopterine as marker for haematological neoplasias. Hausen A, Fuchs D, Grunewald K, Huber H, Konig K, Wachter H. Clin.Chim.Acta (1981) 117: 297-305.

 

Quantitation of urinary uric acid by reversed-phase liquid chromatography. Hausen A, Fuchs D, Konig K, Wachter H. Clin.Chem. (1981) 27: 1455-1456.

 

[Determination of creatinine in urine by high performance liquid chromatography (HPLC) (author’s transl)]. Hausen A, Fuchs D, Wachter H. J.Clin.Chem.Clin.Biochem. (1981) 19: 375-378.